Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases

Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases originating from simple steatosis, progressing through nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis that may lead to hepatocellular...

Full description

Saved in:
Bibliographic Details
Published inHepatobiliary & pancreatic diseases international Vol. 22; no. 4; pp. 333 - 345
Main Authors Shree Harini, Karthik, Ezhilarasan, Devaraj
Format Journal Article
LanguageEnglish
Published Singapore Elsevier B.V 01.08.2023
Department of Pharmacology,Molecular Medicine and Toxicology Lab,Saveetha Dental College,Saveetha Institute of Medical and Technical Sciences(SIMATS),Chennai,Tamil Nadu 600077,India
Subjects
Online AccessGet full text
ISSN1499-3872
DOI10.1016/j.hbpd.2022.10.003

Cover

Abstract Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases originating from simple steatosis, progressing through nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis that may lead to hepatocellular carcinoma (HCC). The pathogenesis of NAFLD is mediated by the triglyceride accumulation followed by proinflammatory cytokines expression leading to inflammation, oxidative stress, and mitochondrial dysfunction denoted as “two-hit hypothesis”, advancing with a “third hit” of insufficient hepatocyte proliferation, leading to the increase in hepatic progenitor cells contributing to fibrosis and HCC. Wnt/β-catenin signaling is responsible for normal liver development, regeneration, hepatic metabolic zonation, ammonia and drug detoxification, hepatobiliary development, etc., maintaining the overall liver homeostasis. The key regulators of canonical Wnt signaling such as LRP6, Wnt1, Wnt3a, β-catenin, GSK-3β, and APC are abnormally regulated in NAFLD. Many experimental studies have shown the aberrated Wnt/β-catenin signaling during the NAFLD progression and NASH to hepatic fibrosis and HCC. Therefore, in this review, we have emphasized the role of Wnt/β-catenin signaling and its modulators that can potentially aid in the inhibition of NAFLD.
AbstractList Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases originating from simple steatosis, progressing through nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis that may lead to hepatocellular carcinoma (HCC). The pathogenesis of NAFLD is mediated by the triglyceride accumulation followed by proinflammatory cytokines expression leading to inflammation, oxidative stress, and mitochondrial dysfunction denoted as "two-hit hypothesis", advancing with a "third hit" of insufficient hepatocyte proliferation, leading to the increase in hepatic progenitor cells contributing to fibrosis and HCC. Wnt/β-catenin signaling is responsible for normal liver development, regeneration, hepatic metabolic zonation, ammonia and drug detoxification, hepatobiliary development, etc., maintaining the overall liver homeostasis. The key regulators of canonical Wnt signaling such as LRP6, Wnt1, Wnt3a, β-catenin, GSK-3β, and APC are abnormally regulated in NAFLD. Many experimental studies have shown the aberrated Wnt/β-catenin signaling during the NAFLD progression and NASH to hepatic fibrosis and HCC. Therefore, in this review, we have emphasized the role of Wnt/β-catenin signaling and its modulators that can potentially aid in the inhibition of NAFLD.Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases originating from simple steatosis, progressing through nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis that may lead to hepatocellular carcinoma (HCC). The pathogenesis of NAFLD is mediated by the triglyceride accumulation followed by proinflammatory cytokines expression leading to inflammation, oxidative stress, and mitochondrial dysfunction denoted as "two-hit hypothesis", advancing with a "third hit" of insufficient hepatocyte proliferation, leading to the increase in hepatic progenitor cells contributing to fibrosis and HCC. Wnt/β-catenin signaling is responsible for normal liver development, regeneration, hepatic metabolic zonation, ammonia and drug detoxification, hepatobiliary development, etc., maintaining the overall liver homeostasis. The key regulators of canonical Wnt signaling such as LRP6, Wnt1, Wnt3a, β-catenin, GSK-3β, and APC are abnormally regulated in NAFLD. Many experimental studies have shown the aberrated Wnt/β-catenin signaling during the NAFLD progression and NASH to hepatic fibrosis and HCC. Therefore, in this review, we have emphasized the role of Wnt/β-catenin signaling and its modulators that can potentially aid in the inhibition of NAFLD.
Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases originating from simple steatosis, progressing through nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis that may lead to hepatocellular carcinoma (HCC). The pathogenesis of NAFLD is mediated by the triglyceride accumulation followed by proinflammatory cytokines expression leading to inflammation, oxidative stress, and mitochondrial dysfunction denoted as “two-hit hypothesis”, advancing with a “third hit” of insufficient hepatocyte proliferation, leading to the increase in hepatic progenitor cells contributing to fibrosis and HCC. Wnt/β-catenin signaling is responsible for normal liver development, regeneration, hepatic metabolic zonation, ammonia and drug detoxification, hepatobiliary development, etc., maintaining the overall liver homeostasis. The key regulators of canonical Wnt signaling such as LRP6, Wnt1, Wnt3a, β-catenin, GSK-3β, and APC are abnormally regulated in NAFLD. Many experimental studies have shown the aberrated Wnt/β-catenin signaling during the NAFLD progression and NASH to hepatic fibrosis and HCC. Therefore, in this review, we have emphasized the role of Wnt/β-catenin signaling and its modulators that can potentially aid in the inhibition of NAFLD.
Nonalcoholic fatty liver disease(NAFLD)is a global health concern associated with significant morbidity and mortality.NAFLD is a spectrum of diseases originating from simple steatosis,progressing through nonalcoholic steatohepatitis(NASH),fibrosis,and cirrhosis that may lead to hepatocellular carcinoma(HCC).The pathogenesis of NAFLD is mediated by the triglyceride accumulation followed by proinflam-matory cytokines expression leading to inflammation,oxidative stress,and mitochondrial dysfunction de-noted as"two-hit hypothesis",advancing with a"third hit"of insufficient hepatocyte proliferation,lead-ing to the increase in hepatic progenitor cells contributing to fibrosis and HCC.Wnt/β-catenin signaling is responsible for normal liver development,regeneration,hepatic metabolic zonation,ammonia and drug detoxification,hepatobiliary development,etc.,maintaining the overall liver homeostasis.The key regula-tors of canonical Wnt signaling such as LRP6,Wnt1,Wnt3a,β-catenin,GSK-3 β,and APC are abnormally regulated in NAFLD.Many experimental studies have shown the aberrated Wnt/β-catenin signaling dur-ing the NAFLD progression and NASH to hepatic fibrosis and HCC.Therefore,in this review,we have em-phasized the role of Wnt/β-catenin signaling and its modulators that can potentially aid in the inhibition of NAFLD.
Author Ezhilarasan, Devaraj
Shree Harini, Karthik
AuthorAffiliation Department of Pharmacology,Molecular Medicine and Toxicology Lab,Saveetha Dental College,Saveetha Institute of Medical and Technical Sciences(SIMATS),Chennai,Tamil Nadu 600077,India
AuthorAffiliation_xml – name: Department of Pharmacology,Molecular Medicine and Toxicology Lab,Saveetha Dental College,Saveetha Institute of Medical and Technical Sciences(SIMATS),Chennai,Tamil Nadu 600077,India
Author_xml – sequence: 1
  givenname: Karthik
  surname: Shree Harini
  fullname: Shree Harini, Karthik
– sequence: 2
  givenname: Devaraj
  surname: Ezhilarasan
  fullname: Ezhilarasan, Devaraj
  email: ezhild@gmail.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36448560$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1uFDEQhb0IIj9wARaol0hoJrbb0z-IDYpIQIrEJhFLq9qu7rjx2IPtTjSz4gg5Y06CR51sskhWVSq_r1x675gcOO-QkA-MLhll1em4vOk2eskp53mwpLQ8IEdMtO2ibGp-SI5jHCnlTbOq3pLDshIid_SIXP126bTDBA__7hUkdMYV0QwOrHFDAU4XJsVi7fVkIfkQi_yevwar_I23RhU9pLQtrLnFUGgTESLGd-RNDzbi-8d6Qq7Pv1-d_Vhc_rr4efbtcqGEKNMCOVOsUtUK604LDm3f9rTrNKgear1ivKdl3eiaqaZiraY1F5pT1uiy6mgDojwhn-e9d-B6cIMc_RTybVEO46C33W4nd9mRkorsR1Z_mtWb4P9OGJNcm6jQWnDopyh5LcoVrdu2zdKPj9KpW6OWm2DWELbyybcsaGaBCj7GgL1UJkEy3qUAxkpG5T4WOcp9LHIfy342n8GfoU_bX4S-zhBmO28NBhmVQadQm4AqSe3Ny_iXZ7jK-RoF9g9uX4P_A_h-vOQ
CitedBy_id crossref_primary_10_1038_s41467_024_51860_2
crossref_primary_10_3389_fendo_2023_1148934
crossref_primary_10_3390_ijms241713326
crossref_primary_10_1016_j_intimp_2024_112821
crossref_primary_10_1016_j_fct_2025_115241
crossref_primary_10_1002_tox_24465
crossref_primary_10_1016_j_isci_2024_110382
crossref_primary_10_3389_fendo_2024_1344376
crossref_primary_10_1016_j_bbadis_2024_167555
crossref_primary_10_1016_j_jcmgh_2023_10_009
crossref_primary_10_1016_j_cca_2024_117892
crossref_primary_10_1021_acs_jnatprod_4c00742
crossref_primary_10_1016_j_hbpd_2023_02_004
crossref_primary_10_1111_jgh_16874
crossref_primary_10_3389_fmed_2024_1454980
crossref_primary_10_2147_JIR_S497737
crossref_primary_10_1016_j_jddst_2024_105467
crossref_primary_10_3389_fgene_2023_1070605
Cites_doi 10.1073/pnas.1006437108
10.1111/cpr.12161
10.1038/35035124
10.18632/oncotarget.12774
10.1073/pnas.1205015109
10.1210/jc.2012-3038
10.1016/j.cyto.2020.155250
10.1007/s11892-009-0034-5
10.1146/annurev-immunol-030409-101311
10.1038/nrgastro.2010.168
10.1073/pnas.1120068109
10.1136/gutjnl-2012-303816
10.1002/hep.20283
10.1172/JCI63539
10.1136/bmj.d3897
10.1038/ncomms1680
10.1053/jhep.2001.23786
10.1016/j.freeradbiomed.2009.07.016
10.7861/clinmedicine.15-6-s77
10.1096/fj.15-271171
10.1126/science.1188280
10.1016/j.cell.2010.07.041
10.1371/journal.pone.0120919
10.1055/s-0028-1091981
10.1016/j.bbrc.2005.03.007
10.1038/nature02924
10.1016/j.cbi.2007.09.003
10.1002/pro.3122
10.1016/j.jhep.2006.02.011
10.1016/j.cld.2017.08.003
10.1016/j.jhep.2006.03.016
10.1177/1479164117738442
10.1016/j.jhep.2014.12.012
10.1007/s13277-012-0331-5
10.1002/hep.23801
10.1038/nrd2154
10.1186/1471-2458-10-237
10.1158/0008-5472.CAN-15-1519
10.1186/s12916-017-0806-8
10.1016/j.cellsig.2013.09.016
10.5009/gnl.2014.8.3.282
10.1097/MOG.0000000000000176
10.1093/emboj/16.13.3797
10.3390/nu7064453
10.1097/MAJ.0b013e3181812879
10.1038/nrm2391
10.1136/pgmj.74.870.193
10.1053/j.gastro.2003.12.047
10.1158/0008-5472.CAN-10-3342
10.1016/j.biopha.2020.110661
10.1126/science.289.5481.950
10.1111/j.1747-0285.2011.01295.x
10.3748/wjg.v20.i26.8393
10.1002/hep.26924
10.1016/j.bpg.2011.02.005
10.1007/s00439-013-1294-3
10.1053/j.gastro.2006.08.042
10.3892/mmr.2016.5148
10.1038/s41591-018-0104-9
10.1002/jcp.30582
10.1055/s-2005-858989
10.1002/jcp.22593
10.1042/cs0920103
10.1371/journal.pone.0015521
10.1074/jbc.M313478200
10.1016/j.apsb.2017.10.003
10.1016/j.metabol.2015.12.012
10.1016/j.mito.2005.10.004
10.1016/S0016-5085(98)70599-2
10.1007/s11010-012-1498-1
10.1016/j.canlet.2009.06.009
10.1016/S0959-8049(16)32668-5
10.2174/138161210791208875
10.3389/fnut.2021.791861
10.1016/j.semcancer.2010.12.010
10.3727/096504017X14992942781895
10.3748/wjg.v24.i27.2974
10.1016/j.jpeds.2012.08.043
10.3748/wjg.v16.i34.4243
10.1097/CCO.0000000000000042
10.1002/hep.28431
10.1016/j.jhep.2009.03.019
10.1177/1535370220949148
10.1136/gutjnl-2014-308969
10.1371/journal.pone.0081710
10.1016/j.cellsig.2017.06.001
10.1634/theoncologist.2012-0211
10.1136/gut.2008.161885
10.1038/ng1732
10.1371/journal.pone.0157246
10.1074/jbc.M410078200
10.1016/S0016-5085(96)70028-8
10.1016/j.jhep.2005.03.004
10.1016/S0002-9440(10)61215-1
10.1002/hep.21131
10.1002/hep.21473
10.1111/j.1572-0241.1999.01377.x
10.1152/ajpgi.00263.2007
10.1016/S0002-9440(10)63489-X
10.1038/nm.3699
10.1128/CMR.12.1.40
10.1074/jbc.M111.286724
10.1093/emboj/18.15.4233
10.3748/wjg.v18.i15.1745
10.1136/gut.2005.071118
10.1126/scisignal.2001249
10.1158/1535-7163.MCT-13-0048
10.1186/s13046-018-0678-6
10.1016/S0024-3205(00)00605-6
10.1016/j.febslet.2007.05.050
10.1038/onc.2015.280
10.4161/epi.5.8.13104
10.1053/j.gastro.2015.02.056
10.1172/JCI34275
10.1074/jbc.M310284200
10.1002/hep.22084
10.1006/jaut.2001.0522
10.1007/s11596-019-2123-2
10.3892/mmr.2014.2099
10.1038/sj.onc.1206118
10.1371/journal.pone.0083819
10.1074/jbc.M109.009647
10.3748/wjg.v22.i48.10512
10.1038/nature05485
10.1021/bi0512602
10.1242/dmm.001180
10.1038/nrgastro.2013.41
10.1053/j.gastro.2010.03.052
10.1016/j.bbadis.2017.12.001
10.1016/j.metabol.2016.06.009
10.1016/j.lfs.2003.07.017
10.1158/0008-5472.CAN-14-2041
10.1002/hep.23337
10.1038/ng.257
10.1016/j.cld.2009.07.005
10.1152/ajpgi.90223.2008
10.1016/j.jphs.2018.01.003
10.1111/j.1572-0241.2004.30159.x
10.1016/j.bcp.2020.113942
10.1007/s00418-008-0546-0
10.1053/j.gastro.2008.03.003
10.2353/ajpath.2010.090667
10.1155/2020/4910601
10.1038/nrgastro.2017.109
10.1016/j.biopha.2018.11.149
10.1016/j.jhep.2010.04.008
10.7150/ijbs.14718
10.1038/nm1166
10.1158/0008-5472.CAN-14-3786
10.1016/j.taap.2014.03.008
10.1073/pnas.1119964109
ContentType Journal Article
Copyright 2022
Copyright © 2022. Published by Elsevier B.V.
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: 2022
– notice: Copyright © 2022. Published by Elsevier B.V.
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID AAYXX
CITATION
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1016/j.hbpd.2022.10.003
DatabaseName CrossRef
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 345
ExternalDocumentID gjgdybzz_z202304003
36448560
10_1016_j_hbpd_2022_10_003
S1499387222002399
Genre Journal Article
Review
GroupedDBID ---
--K
-05
-0E
-SE
-S~
.1-
.FO
.~1
0R~
1P~
1~.
2WC
4.4
457
4G.
53G
5GY
5VR
7-5
8RM
92F
92I
92M
9D9
9DE
AAEDT
AAEDW
AAKOC
AALRI
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABKZE
ABMAC
ABWVN
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFPUW
AFRHN
AFTJW
AFUIB
AFXIZ
AGCQF
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BNPGV
C1A
CAJEE
CCEZO
CHBEP
CIEJG
DIK
EBS
EFJIC
EFKBS
EJD
F5P
FDB
FIRID
FNPLU
FRP
FYGXN
GBLVA
GX1
HZ~
JUIAU
KOM
M41
MO0
O-L
O9-
OC.
OK1
P-8
P-9
P6G
PC.
Q--
Q-4
Q38
ROL
RT5
S..
SDF
SES
SPCBC
SSH
SSZ
T5K
T8U
TCJ
TGQ
U1F
U1G
U5E
U5O
W2D
WFFXF
Z5R
~G-
188
2B.
2C~
93N
93R
AACTN
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
CAJUS
EFLBG
FA0
R-E
RIG
UZ5
AAYXX
AGRNS
CITATION
NPM
7X8
ACLOT
~HD
4A8
PSX
ID FETCH-LOGICAL-c443t-e21c16c65e7bd42a9f9f0bbdacfa7d512f0378d71c8619d0724d2018d36b08a43
IEDL.DBID AIKHN
ISSN 1499-3872
IngestDate Thu May 29 04:07:36 EDT 2025
Sat Sep 27 20:27:06 EDT 2025
Mon Jul 21 06:00:37 EDT 2025
Tue Jul 01 01:41:32 EDT 2025
Thu Apr 24 23:04:01 EDT 2025
Fri Feb 23 02:34:57 EST 2024
Tue Aug 26 16:37:34 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Oxidative stress
Chronic liver diseases
Fatty liver
Wnt/β-catenin
Fibrosis
Steatosis
Language English
License Copyright © 2022. Published by Elsevier B.V.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c443t-e21c16c65e7bd42a9f9f0bbdacfa7d512f0378d71c8619d0724d2018d36b08a43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 36448560
PQID 2743507999
PQPubID 23479
PageCount 13
ParticipantIDs wanfang_journals_gjgdybzz_z202304003
proquest_miscellaneous_2743507999
pubmed_primary_36448560
crossref_citationtrail_10_1016_j_hbpd_2022_10_003
crossref_primary_10_1016_j_hbpd_2022_10_003
elsevier_sciencedirect_doi_10_1016_j_hbpd_2022_10_003
elsevier_clinicalkey_doi_10_1016_j_hbpd_2022_10_003
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-08-01
PublicationDateYYYYMMDD 2023-08-01
PublicationDate_xml – month: 08
  year: 2023
  text: 2023-08-01
  day: 01
PublicationDecade 2020
PublicationPlace Singapore
PublicationPlace_xml – name: Singapore
PublicationTitle Hepatobiliary & pancreatic diseases international
PublicationTitleAlternate Hepatobiliary Pancreat Dis Int
PublicationTitle_FL Hepatobiliary & Pancreatic Diseases International
PublicationYear 2023
Publisher Elsevier B.V
Department of Pharmacology,Molecular Medicine and Toxicology Lab,Saveetha Dental College,Saveetha Institute of Medical and Technical Sciences(SIMATS),Chennai,Tamil Nadu 600077,India
Publisher_xml – name: Elsevier B.V
– name: Department of Pharmacology,Molecular Medicine and Toxicology Lab,Saveetha Dental College,Saveetha Institute of Medical and Technical Sciences(SIMATS),Chennai,Tamil Nadu 600077,India
References Kim, Kisseleva, Brenner (bib0009) 2015; 31
Kanazawa, Tsukada, Kamiyama, Yanagimoto, Nakajima, Maeda (bib0145) 2005; 330
Yeh, Krauland, Singh, Zou, Devaraj, Stolz (bib0074) 2010; 52
Ackers, Malgor (bib0076) 2018; 15
Fang, Hou, Chang, Hsiu, Chao, Chiang (bib0148) 2003; 74
Ross, Hemati, Longo, Bennett, Lucas, Erickson (bib0096) 2000; 289
Behari, Yeh, Krauland, Otruba, Cieply, Hauth (bib0087) 2010; 176
Madan, Ke, Harmston, Ho, Frois, Alam (bib0141) 2016; 35
Gougelet, Sartor, Bachelot, Godard, Marchiol, Renault (bib0113) 2016; 65
Aragno, Tomasinelli, Vercellinatto, Catalano, Collino, Fantozzi (bib0023) 2009; 47
Hazra, Xiong, Wang, Rippe, Krishna, Chatterjee (bib0097) 2004; 279
Liu, Fergusson, Wu, Rovira, Liu, Gavrilova (bib0082) 2011; 4
Friedman (bib0056) 2008; 134
Brunt, Janney, Di Bisceglie, Neuschwander-Tetri, Bacon (bib0003) 1999; 94
Cohen, Stemmer, Zozulya, Ochaion, Patoka, Barer (bib0130) 2011; 226
Roskams, Yang, Koteish, Durnez, DeVos, Huang (bib0032) 2003; 163
Micsenyi, Tan, Sneddon, Luo, Michalopoulos, Monga (bib0066) 2004; 126
Fako, Yu, Henrich, Ransom, Budhu, Wang (bib0133) 2016; 12
Ge, Wang, Wu, Fan, Chen (bib0094) 2014; 9
Younossi, Anstee, Marietti, Hardy, Henry, Eslam (bib0004) 2018; 15
Nejak-Bowen, Monga (bib0070) 2011; 21
Du, Ren, Zhang, Fu, Han, Cui (bib0101) 2020; 2020
de la Roche, Rutherford, Gupta, Veprintsev, Saxty, Freund (bib0117) 2012; 3
Pinson, Brennan, Monkley, Avery, Skarnes (bib0062) 2000; 407
Zhang, Pan, Zhang, Yan, Yu, Wu (bib0100) 2013; 374
Wang, Wang, Huang, Chen, Lü, Shi (bib0077) 2019; 44
Kotronen, Yki-Järvinen, Männistö, Saarikoski, Korpi-Hyövälti, Oksa (bib0020) 2010; 10
Wu, Chen, Chen, Lin, Tseng (bib0150) 2010; 287
She, Xiong, Hazra, Tsukamoto (bib0098) 2005; 280
Sun, Chen, Wen, Sun, An, Pang (bib0153) 2018; 136
Weltman, Farrell, Liddle (bib0039) 1996; 111
Wang, Dong, Liu, Ni, Sai, You (bib0135) 2020; 131
Tian, Wong, Wong, Yang, Sun, Shen (bib0111) 2015; 75
Akcora, Storm, Bansal (bib0144) 2018; 1864
Argo, Caldwell (bib0012) 2009; 13
Kitamoto, Kitamoto, Yoneda, Hyogo, Ochi, Nakamura (bib0011) 2013; 132
Postic, Girard (bib0034) 2008; 118
Grant, Thorleifsson, Reynisdottir, Benediktsson, Manolescu, Sainz (bib0084) 2006; 38
Tian, Zhang, Li, Xie (bib0129) 2014; 9
Zhang, Haughey, Wang, Blease, Kapoun, Couto (bib0139) 2020; 15
Cheng, She, Han, Wang, Xiong, Asahina (bib0091) 2008; 294
Byrne, Targher (bib0007) 2015; 62
Sekine, Lan, Bedolli, Feng, Hebrok (bib0073) 2006; 43
Shan, Zhang, Bao, Cassell, Zheng (bib0123) 2012; 79
Polosukhina, Love, Moses, Lee, Zent, Clark (bib0126) 2017; 25
Li, Xi, Tinsley, Gurpinar, Gary, Zhu (bib0125) 2013; 12
El-Derany, El-Demerdash (bib0128) 2020; 177
Friedman, Neuschwander-Tetri, Rinella, Sanyal (bib0018) 2018; 24
Chalasani, Deeg, Crabb (bib0036) 2004; 99
Kim, Park, Lee, Lee, Jeon, Kim (bib0014) 2009; 337
Ezhilarasan (bib0052) 2020; 245
Stienstra, Saudale, Duval, Keshtkar, Groener, van Rooijen (bib0047) 2010; 51
Boschert, van Dinther, Weidauer, van Pee, Muth, Ten Dijke (bib0120) 2013; 8
Aberle, Bauer, Stappert, Kispert, Kemler (bib0061) 1997; 16
Tan, Behari, Cieply, Michalopoulos, Monga (bib0068) 2006; 131
Hsu, Wang, Kota, Yu, Costinean, Kutay (bib0112) 2012; 122
Monga, Hout, Baun, Micsenyi, Muller, Tummalapalli (bib0067) 2005; 167
Buzzetti, Pinzani, Tsochatzis (bib0027) 2016; 65
Sahin, Trautwein, Wasmuth (bib0053) 2010; 7
Zhang, Song, Yang, Dai, Li, Wang (bib0124) 2015; 48
Stemmer, Benjaminov, Medalia, Ciuraru, Silverman, Bar-Yehuda (bib0131) 2013; 18
Jang, Hong, Kim, Lee, Park, Lee (bib0142) 2015; 75
Gross, Wan, Birnbaum (bib0083) 2009; 9
Rowell, Anstee (bib0001) 2015; 15
Younossi, Koenig, Abdelatif, Fazel, Henry, Wymer (bib0005) 2016; 64
Anstee, Targher, Day (bib0022) 2013; 10
Tao, Zhang, Zeng, Shulman, Jin (bib0137) 2014; 20
Register, Hruska, Divers, Bowden, Palmer, Carr (bib0081) 2013; 98
Lade, Noon, Friedman (bib0057) 2014; 26
Sheehan, Hitchcock, Sibley (bib0134) 1999; 12
Son, Kojima, Decaens, Yamaguchi, Ito, Imamura (bib0075) 2009; 131
Feldstein, Werneburg, Canbay, Guicciardi, Bronk, Rydzewski (bib0029) 2004; 40
Jia, Yuan, Xu, Li, Yang, Jiang (bib0152) 2016; 13
Liu, Singh, Choi, Lee, Keramati, Samuel (bib0079) 2012; 287
Le Roy, Llopis, Lepage, Bruneau, Rabot, Bevilacqua (bib0016) 2013; 62
Neuschwander-Tetri (bib0035) 2017; 15
Sivaramakrishnan, Shilpa, Praveen Kumar, Niranjali Devaraj (bib0147) 2008; 171
Breitkopf, Godoy, Ciuclan, Singer, Dooley (bib0051) 2006; 44
Saraswati, Alfaro, Thorne, Atkinson, Lee, Young (bib0127) 2010; 5
Huang (bib0017) 2009; 2
Bendell, Eckhardt, Hochster, Morris, Strickler, Kapoun (bib0140) 2016; 69
Wu, Wang, Qian, Qiao, Zou, Chen (bib0114) 2017; 37
Samuel, Liu, Qu, Elder, Bilz, Befroy (bib0088) 2004; 279
Xiao, Xing, Liu, Lv, Wang, Ling (bib0107) 2018; 8
Hotamisligil (bib0040) 2006; 444
Kok, Wong, Wu, Chan, Kwok, Fung (bib0146) 2000; 67
Kaur, Mani, Cros, Scoazec, Chemin, Hainaut (bib0108) 2012; 33
Alcolado, Arthur, Iredale (bib0059) 1997; 92
Williams, Iredale (bib0058) 1998; 74
Barrott, Cash, Smith, Barrow, Murtaugh (bib0064) 2011; 108
Lee, Friedman (bib0055) 2011; 25
Lindenmeyer, McCullough (bib0006) 2018; 22
Welsh, Karpen, Vos (bib0024) 2013; 162
Cadoret, Ovejero, Terris, Souil, Lévy, Lamers (bib0072) 2002; 21
Jiang, Parsons, Stefanovic (bib0099) 2006; 45
Romeo, Kozlitina, Xing, Pertsemlidis, Cox, Pennacchio (bib0010) 2008; 40
Zhang, Yuan, He, Lei, Wang (bib0049) 2016; 22
Ratziu, Bellentani, Cortez-Pinto, Day, Marchesini (bib0033) 2010; 53
Gurney, Axelrod, Bond, Cain, Chartier, Donigan (bib0118) 2012; 109
Myung, Yoon, Gwak, Kim, Lee, Kim (bib0092) 2007; 581
Xavier, Melikova, Chuman, Üren, Baljinnyam, Rubin (bib0119) 2014; 26
Watanabe, Sohail, Gomes, Hashmi, Nagata, Sutterwala (bib0045) 2009; 296
Klein, Demory, Peyre, Kroll, Augustin, Helfrich (bib0103) 2008; 47
Guo, Zhou, Yang, Shao (bib0155) 2019; 110
Li, Shan, Chang, Kim, Bao, Lee (bib0085) 2012; 109
Bugianesi, Moscatiello, Ciaravella, Marchesini (bib0028) 2010; 16
Ahmed, Byrne (bib0015) 2010; 16
Pessayre, Fromenty (bib0037) 2005; 42
Rock, Latz, Ontiveros, Kono (bib0046) 2010; 28
Jia, Yang, Liu, Herman, Lu, Guo (bib0109) 2010; 5
MadanKumar, NaveenKumar, Manikandan, Devaraj, NiranjaliDevaraj (bib0149) 2014; 277
Guilherme, Virbasius, Puri, Czech (bib0030) 2008; 9
Begriche, Igoudjil, Pessayre, Fromenty (bib0038) 2006; 6
Miura, Kodama, Inokuchi, Schnabl, Aoyama, Ohnishi (bib0048) 2010; 139
Fang, Chen, Wang, Liang (bib0025) 2018; 24
Ouchi, Higuchi, Ohashi, Oshima, Gokce, Shibata (bib0089) 2010; 329
El-Ashmawy, Al-Ashmawy, Fakher, Khedr (bib0138) 2020; 136
Wang, Song, Srivastava, Dong, Go, Li (bib0086) 2015; 29
Shan, Shi, Wang, Zheng (bib0121) 2005; 44
Tomita, Tamiya, Ando, Ohsumi, Chiyo, Mizutani (bib0042) 2006; 55
Zhao, Ye, Gao, Li (bib0154) 2019; 39
Grandy, Shan, Zhang, Rao, Akunuru, Li (bib0122) 2009; 284
Go (bib0080) 2015; 7
Toshikuni, Tsutsumi, Arisawa (bib0021) 2014; 20
Li, Zhu, Li, Wu, Gao (bib0095) 2014; 8
Monga, Pediaditakis, Mule, Stolz, Michalopoulos (bib0069) 2001; 33
Cai, Yuan, Frantz, Melendez, Hansen, Lee (bib0041) 2005; 11
Käräjämäki, Bloigu, Kauma, Kesäniemi, Koivurova, Perkiömäki (bib0019) 2017; 66
Zhang, Liu, Yu, Li, Li (bib0151) 2018; 37
Katanaev (bib0063) 2010; 75
Pikarsky, Porat, Stein, Abramovitch, Amit, Kasem (bib0044) 2004; 431
Tanaka, Leung, Kenny, Au-Young, Prindiville, Coppel (bib0090) 2001; 17
Jou, Choi, Diehl (bib0031) 2008; 28
Carpino, Nobili, Renzi, De Stefanis, Stronati, Franchitto (bib0105) 2016; 11
Oh, Talukdar, Bae, Imamura, Morinaga, Fan (bib0136) 2010; 142
Chang, Ryu, Sung, Woo, Cho, Yoo (bib0013) 2009; 58
Li, Gong, Wang, Liu, Chu, Gui (bib0104) 2021; 8
Fonseca, Predes, Cerqueira, Reis, Amado, Cayres (bib0116) 2015; 10
Li, Yuan, Weaver, Mao, Farr, Sussman (bib0065) 1999; 18
Fang, Zhu, Neuenschwander, Specker, Wulf-Goldenberg, Weis (bib0143) 2016; 76
Ramachandran, Pellicoro, Vernon, Boulter, Aucott, Ali (bib0054) 2012; 109
Cheng, Lau, Chen, Kondo, Li, Feng (bib0110) 2011; 71
Zeng, Awan, Otruba, Muller, Apte, Tan (bib0102) 2007; 45
Tran, Zheng (bib0115) 2017; 26
Gougelet, Torre, Veber, Sartor, Bachelot, Denechaud (bib0071) 2014; 59
Monga (bib0060) 2015; 148
Anstee, McPherson, Day (bib0002) 2011; 343
Ezhilarasan (bib0050) 2022; 237
Xiong, Hu, Jian, Wang, Jiang, Li (bib0093) 2012; 18
Argo, Northup, Al-Osaimi, Caldwell (bib0008) 2009; 51
Day, James (bib0026) 1998; 114
Zhou, Song, Peng, Zhou, Wei, Zhou (bib0078) 2016; 7
Fishman, Cohen, Itzhak, Amer, Salhab, Barer (bib0132) 2019; 44
Haukeland, Damås, Konopski, Løberg, Haaland, Goverud (bib0043) 2006; 44
Barker, Clevers (bib0106) 2006; 5
Zhao (10.1016/j.hbpd.2022.10.003_bib0154) 2019; 39
Lade (10.1016/j.hbpd.2022.10.003_bib0057) 2014; 26
Klein (10.1016/j.hbpd.2022.10.003_bib0103) 2008; 47
Fang (10.1016/j.hbpd.2022.10.003_bib0148) 2003; 74
Wang (10.1016/j.hbpd.2022.10.003_bib0086) 2015; 29
Barker (10.1016/j.hbpd.2022.10.003_bib0106) 2006; 5
Liu (10.1016/j.hbpd.2022.10.003_bib0079) 2012; 287
Stienstra (10.1016/j.hbpd.2022.10.003_bib0047) 2010; 51
Pinson (10.1016/j.hbpd.2022.10.003_bib0062) 2000; 407
Cohen (10.1016/j.hbpd.2022.10.003_bib0130) 2011; 226
Friedman (10.1016/j.hbpd.2022.10.003_bib0018) 2018; 24
Boschert (10.1016/j.hbpd.2022.10.003_bib0120) 2013; 8
Ahmed (10.1016/j.hbpd.2022.10.003_bib0015) 2010; 16
Ratziu (10.1016/j.hbpd.2022.10.003_bib0033) 2010; 53
Gougelet (10.1016/j.hbpd.2022.10.003_bib0071) 2014; 59
Jia (10.1016/j.hbpd.2022.10.003_bib0109) 2010; 5
Argo (10.1016/j.hbpd.2022.10.003_bib0008) 2009; 51
Argo (10.1016/j.hbpd.2022.10.003_bib0012) 2009; 13
Kanazawa (10.1016/j.hbpd.2022.10.003_bib0145) 2005; 330
Bendell (10.1016/j.hbpd.2022.10.003_bib0140) 2016; 69
Sun (10.1016/j.hbpd.2022.10.003_bib0153) 2018; 136
Miura (10.1016/j.hbpd.2022.10.003_bib0048) 2010; 139
Hotamisligil (10.1016/j.hbpd.2022.10.003_bib0040) 2006; 444
Kotronen (10.1016/j.hbpd.2022.10.003_bib0020) 2010; 10
Liu (10.1016/j.hbpd.2022.10.003_bib0082) 2011; 4
Fang (10.1016/j.hbpd.2022.10.003_bib0143) 2016; 76
Xiong (10.1016/j.hbpd.2022.10.003_bib0093) 2012; 18
Jiang (10.1016/j.hbpd.2022.10.003_bib0099) 2006; 45
Zhang (10.1016/j.hbpd.2022.10.003_bib0151) 2018; 37
Le Roy (10.1016/j.hbpd.2022.10.003_bib0016) 2013; 62
Rowell (10.1016/j.hbpd.2022.10.003_bib0001) 2015; 15
Chang (10.1016/j.hbpd.2022.10.003_bib0013) 2009; 58
Brunt (10.1016/j.hbpd.2022.10.003_bib0003) 1999; 94
Neuschwander-Tetri (10.1016/j.hbpd.2022.10.003_bib0035) 2017; 15
Monga (10.1016/j.hbpd.2022.10.003_bib0067) 2005; 167
She (10.1016/j.hbpd.2022.10.003_bib0098) 2005; 280
Fonseca (10.1016/j.hbpd.2022.10.003_bib0116) 2015; 10
Aberle (10.1016/j.hbpd.2022.10.003_bib0061) 1997; 16
Madan (10.1016/j.hbpd.2022.10.003_bib0141) 2016; 35
MadanKumar (10.1016/j.hbpd.2022.10.003_bib0149) 2014; 277
Younossi (10.1016/j.hbpd.2022.10.003_bib0005) 2016; 64
Monga (10.1016/j.hbpd.2022.10.003_bib0060) 2015; 148
Jou (10.1016/j.hbpd.2022.10.003_bib0031) 2008; 28
Ramachandran (10.1016/j.hbpd.2022.10.003_bib0054) 2012; 109
Micsenyi (10.1016/j.hbpd.2022.10.003_bib0066) 2004; 126
Wang (10.1016/j.hbpd.2022.10.003_bib0077) 2019; 44
Käräjämäki (10.1016/j.hbpd.2022.10.003_bib0019) 2017; 66
Pessayre (10.1016/j.hbpd.2022.10.003_bib0037) 2005; 42
Welsh (10.1016/j.hbpd.2022.10.003_bib0024) 2013; 162
Li (10.1016/j.hbpd.2022.10.003_bib0125) 2013; 12
Tao (10.1016/j.hbpd.2022.10.003_bib0137) 2014; 20
Pikarsky (10.1016/j.hbpd.2022.10.003_bib0044) 2004; 431
Day (10.1016/j.hbpd.2022.10.003_bib0026) 1998; 114
Ezhilarasan (10.1016/j.hbpd.2022.10.003_bib0052) 2020; 245
Xavier (10.1016/j.hbpd.2022.10.003_bib0119) 2014; 26
Behari (10.1016/j.hbpd.2022.10.003_bib0087) 2010; 176
Byrne (10.1016/j.hbpd.2022.10.003_bib0007) 2015; 62
Buzzetti (10.1016/j.hbpd.2022.10.003_bib0027) 2016; 65
Zhang (10.1016/j.hbpd.2022.10.003_bib0100) 2013; 374
Li (10.1016/j.hbpd.2022.10.003_bib0085) 2012; 109
Gross (10.1016/j.hbpd.2022.10.003_bib0083) 2009; 9
Wang (10.1016/j.hbpd.2022.10.003_bib0135) 2020; 131
Kim (10.1016/j.hbpd.2022.10.003_bib0014) 2009; 337
Sivaramakrishnan (10.1016/j.hbpd.2022.10.003_bib0147) 2008; 171
Zhang (10.1016/j.hbpd.2022.10.003_bib0124) 2015; 48
Alcolado (10.1016/j.hbpd.2022.10.003_bib0059) 1997; 92
Grant (10.1016/j.hbpd.2022.10.003_bib0084) 2006; 38
Breitkopf (10.1016/j.hbpd.2022.10.003_bib0051) 2006; 44
Ouchi (10.1016/j.hbpd.2022.10.003_bib0089) 2010; 329
El-Derany (10.1016/j.hbpd.2022.10.003_bib0128) 2020; 177
Williams (10.1016/j.hbpd.2022.10.003_bib0058) 1998; 74
Tan (10.1016/j.hbpd.2022.10.003_bib0068) 2006; 131
Zhou (10.1016/j.hbpd.2022.10.003_bib0078) 2016; 7
Bugianesi (10.1016/j.hbpd.2022.10.003_bib0028) 2010; 16
Roskams (10.1016/j.hbpd.2022.10.003_bib0032) 2003; 163
Guilherme (10.1016/j.hbpd.2022.10.003_bib0030) 2008; 9
Toshikuni (10.1016/j.hbpd.2022.10.003_bib0021) 2014; 20
Nejak-Bowen (10.1016/j.hbpd.2022.10.003_bib0070) 2011; 21
Tian (10.1016/j.hbpd.2022.10.003_bib0129) 2014; 9
Wu (10.1016/j.hbpd.2022.10.003_bib0150) 2010; 287
Aragno (10.1016/j.hbpd.2022.10.003_bib0023) 2009; 47
Li (10.1016/j.hbpd.2022.10.003_bib0065) 1999; 18
Ross (10.1016/j.hbpd.2022.10.003_bib0096) 2000; 289
Shan (10.1016/j.hbpd.2022.10.003_bib0123) 2012; 79
Cadoret (10.1016/j.hbpd.2022.10.003_bib0072) 2002; 21
Cheng (10.1016/j.hbpd.2022.10.003_bib0091) 2008; 294
Romeo (10.1016/j.hbpd.2022.10.003_bib0010) 2008; 40
Li (10.1016/j.hbpd.2022.10.003_bib0095) 2014; 8
Wu (10.1016/j.hbpd.2022.10.003_bib0114) 2017; 37
Postic (10.1016/j.hbpd.2022.10.003_bib0034) 2008; 118
Jang (10.1016/j.hbpd.2022.10.003_bib0142) 2015; 75
Fako (10.1016/j.hbpd.2022.10.003_bib0133) 2016; 12
Rock (10.1016/j.hbpd.2022.10.003_bib0046) 2010; 28
Go (10.1016/j.hbpd.2022.10.003_bib0080) 2015; 7
Zhang (10.1016/j.hbpd.2022.10.003_bib0139) 2020; 15
Myung (10.1016/j.hbpd.2022.10.003_bib0092) 2007; 581
Fishman (10.1016/j.hbpd.2022.10.003_bib0132) 2019; 44
Cai (10.1016/j.hbpd.2022.10.003_bib0041) 2005; 11
Saraswati (10.1016/j.hbpd.2022.10.003_bib0127) 2010; 5
Oh (10.1016/j.hbpd.2022.10.003_bib0136) 2010; 142
Lee (10.1016/j.hbpd.2022.10.003_bib0055) 2011; 25
Anstee (10.1016/j.hbpd.2022.10.003_bib0002) 2011; 343
Son (10.1016/j.hbpd.2022.10.003_bib0075) 2009; 131
Zeng (10.1016/j.hbpd.2022.10.003_bib0102) 2007; 45
Huang (10.1016/j.hbpd.2022.10.003_bib0017) 2009; 2
El-Ashmawy (10.1016/j.hbpd.2022.10.003_bib0138) 2020; 136
Sahin (10.1016/j.hbpd.2022.10.003_bib0053) 2010; 7
Kim (10.1016/j.hbpd.2022.10.003_bib0009) 2015; 31
Hsu (10.1016/j.hbpd.2022.10.003_bib0112) 2012; 122
Ezhilarasan (10.1016/j.hbpd.2022.10.003_bib0050) 2022; 237
Kaur (10.1016/j.hbpd.2022.10.003_bib0108) 2012; 33
Kok (10.1016/j.hbpd.2022.10.003_bib0146) 2000; 67
Weltman (10.1016/j.hbpd.2022.10.003_bib0039) 1996; 111
Gurney (10.1016/j.hbpd.2022.10.003_bib0118) 2012; 109
Barrott (10.1016/j.hbpd.2022.10.003_bib0064) 2011; 108
Du (10.1016/j.hbpd.2022.10.003_bib0101) 2020; 2020
Feldstein (10.1016/j.hbpd.2022.10.003_bib0029) 2004; 40
Monga (10.1016/j.hbpd.2022.10.003_bib0069) 2001; 33
Li (10.1016/j.hbpd.2022.10.003_bib0104) 2021; 8
Lindenmeyer (10.1016/j.hbpd.2022.10.003_bib0006) 2018; 22
Katanaev (10.1016/j.hbpd.2022.10.003_bib0063) 2010; 75
Sekine (10.1016/j.hbpd.2022.10.003_bib0073) 2006; 43
Samuel (10.1016/j.hbpd.2022.10.003_bib0088) 2004; 279
Haukeland (10.1016/j.hbpd.2022.10.003_bib0043) 2006; 44
Ge (10.1016/j.hbpd.2022.10.003_bib0094) 2014; 9
Carpino (10.1016/j.hbpd.2022.10.003_bib0105) 2016; 11
Friedman (10.1016/j.hbpd.2022.10.003_bib0056) 2008; 134
Tran (10.1016/j.hbpd.2022.10.003_bib0115) 2017; 26
Watanabe (10.1016/j.hbpd.2022.10.003_bib0045) 2009; 296
Polosukhina (10.1016/j.hbpd.2022.10.003_bib0126) 2017; 25
Stemmer (10.1016/j.hbpd.2022.10.003_bib0131) 2013; 18
Sheehan (10.1016/j.hbpd.2022.10.003_bib0134) 1999; 12
Tian (10.1016/j.hbpd.2022.10.003_bib0111) 2015; 75
Anstee (10.1016/j.hbpd.2022.10.003_bib0022) 2013; 10
Xiao (10.1016/j.hbpd.2022.10.003_bib0107) 2018; 8
Kitamoto (10.1016/j.hbpd.2022.10.003_bib0011) 2013; 132
de la Roche (10.1016/j.hbpd.2022.10.003_bib0117) 2012; 3
Shan (10.1016/j.hbpd.2022.10.003_bib0121) 2005; 44
Begriche (10.1016/j.hbpd.2022.10.003_bib0038) 2006; 6
Younossi (10.1016/j.hbpd.2022.10.003_bib0004) 2018; 15
Tomita (10.1016/j.hbpd.2022.10.003_bib0042) 2006; 55
Yeh (10.1016/j.hbpd.2022.10.003_bib0074) 2010; 52
Register (10.1016/j.hbpd.2022.10.003_bib0081) 2013; 98
Cheng (10.1016/j.hbpd.2022.10.003_bib0110) 2011; 71
Guo (10.1016/j.hbpd.2022.10.003_bib0155) 2019; 110
Chalasani (10.1016/j.hbpd.2022.10.003_bib0036) 2004; 99
Hazra (10.1016/j.hbpd.2022.10.003_bib0097) 2004; 279
Gougelet (10.1016/j.hbpd.2022.10.003_bib0113) 2016; 65
Grandy (10.1016/j.hbpd.2022.10.003_bib0122) 2009; 284
Tanaka (10.1016/j.hbpd.2022.10.003_bib0090) 2001; 17
Ackers (10.1016/j.hbpd.2022.10.003_bib0076) 2018; 15
Zhang (10.1016/j.hbpd.2022.10.003_bib0049) 2016; 22
Jia (10.1016/j.hbpd.2022.10.003_bib0152) 2016; 13
Akcora (10.1016/j.hbpd.2022.10.003_bib0144) 2018; 1864
Fang (10.1016/j.hbpd.2022.10.003_bib0025) 2018; 24
References_xml – volume: 108
  start-page: 12752
  year: 2011
  end-page: 12757
  ident: bib0064
  article-title: Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome
  publication-title: Proc Natl Acad Sci U S A
– volume: 279
  start-page: 11392
  year: 2004
  end-page: 11401
  ident: bib0097
  article-title: Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells
  publication-title: J Biol Chem
– volume: 10
  start-page: 237
  year: 2010
  ident: bib0020
  article-title: Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey
  publication-title: BMC Public Health
– volume: 76
  start-page: 891
  year: 2016
  end-page: 901
  ident: bib0143
  article-title: A small-molecule antagonist of the β-catenin/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis
  publication-title: Cancer Res
– volume: 79
  start-page: 376
  year: 2012
  end-page: 383
  ident: bib0123
  article-title: Synthesis of potent dishevelled PDZ domain inhibitors guided by virtual screening and NMR studies
  publication-title: Chem Biol Drug Des
– volume: 20
  start-page: 1263
  year: 2014
  end-page: 1269
  ident: bib0137
  article-title: Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice
  publication-title: Nat Med
– volume: 26
  start-page: 94
  year: 2014
  end-page: 101
  ident: bib0119
  article-title: Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signaling
  publication-title: Cell Signal
– volume: 12
  start-page: 1848
  year: 2013
  end-page: 1859
  ident: bib0125
  article-title: Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling
  publication-title: Mol Cancer Ther
– volume: 9
  start-page: 367
  year: 2008
  end-page: 377
  ident: bib0030
  article-title: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
  publication-title: Nat Rev Mol Cell Biol
– volume: 109
  start-page: 11402
  year: 2012
  end-page: 11407
  ident: bib0085
  article-title: Chemical and genetic evidence for the involvement of Wnt antagonist Dickkopf2 in regulation of glucose metabolism
  publication-title: Proc Natl Acad Sci U S A
– volume: 3
  start-page: 680
  year: 2012
  ident: bib0117
  article-title: An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid
  publication-title: Nat Commun
– volume: 287
  start-page: 187
  year: 2010
  end-page: 195
  ident: bib0150
  article-title: Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice
  publication-title: Cancer Lett
– volume: 177
  year: 2020
  ident: bib0128
  article-title: Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk
  publication-title: Biochem Pharmacol
– volume: 8
  start-page: 282
  year: 2014
  end-page: 291
  ident: bib0095
  article-title: Mest attenuates CCl4-induced liver fibrosis in rats by inhibiting the Wnt/β-catenin signaling pathway
  publication-title: Gut Liver
– volume: 17
  start-page: 89
  year: 2001
  end-page: 98
  ident: bib0090
  article-title: Genomic analysis of differentially expressed genes in liver and biliary epithelial cells of patients with primary biliary cirrhosis
  publication-title: J Autoimmun
– volume: 43
  start-page: 817
  year: 2006
  end-page: 825
  ident: bib0073
  article-title: Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice
  publication-title: Hepatology
– volume: 126
  start-page: 1134
  year: 2004
  end-page: 1146
  ident: bib0066
  article-title: Beta-catenin is temporally regulated during normal liver development
  publication-title: Gastroenterology
– volume: 374
  start-page: 13
  year: 2013
  end-page: 20
  ident: bib0100
  article-title: Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through promoting the ROS production
  publication-title: Mol Cell Biochem
– volume: 12
  start-page: 768
  year: 2016
  end-page: 775
  ident: bib0133
  article-title: Inhibition of wnt/β-catenin signaling in hepatocellular carcinoma by an antipsychotic drug pimozide
  publication-title: Int J Biol Sci
– volume: 37
  start-page: 7
  year: 2018
  ident: bib0151
  article-title: The plant alkaloid tetrandrine inhibits metastasis via autophagy-dependent Wnt/β-catenin and metastatic tumor antigen 1 signaling in human liver cancer cells
  publication-title: J Exp Clin Cancer Res
– volume: 16
  start-page: 1941
  year: 2010
  end-page: 1951
  ident: bib0028
  article-title: Insulin resistance in nonalcoholic fatty liver disease
  publication-title: Curr Pharm Des
– volume: 109
  start-page: E3186
  year: 2012
  end-page: E3195
  ident: bib0054
  article-title: Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
  publication-title: Proc Natl Acad Sci U S A
– volume: 62
  start-page: 1787
  year: 2013
  end-page: 1794
  ident: bib0016
  article-title: Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
  publication-title: Gut
– volume: 38
  start-page: 320
  year: 2006
  end-page: 323
  ident: bib0084
  article-title: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
  publication-title: Nat Genet
– volume: 237
  start-page: 436
  year: 2022
  end-page: 449
  ident: bib0050
  article-title: Hepatic stellate cells in the injured liver: perspectives beyond hepatic fibrosis
  publication-title: J Cell Physiol
– volume: 114
  start-page: 842
  year: 1998
  end-page: 845
  ident: bib0026
  article-title: Steatohepatitis: a tale of two "hits"?
  publication-title: Gastroenterology
– volume: 9
  start-page: 208
  year: 2009
  end-page: 214
  ident: bib0083
  article-title: The role of FOXO in the regulation of metabolism
  publication-title: Curr Diab Rep
– volume: 37
  start-page: 62
  year: 2017
  end-page: 73
  ident: bib0114
  article-title: Sirt1 suppresses Wnt/βCatenin signaling in liver cancer cells by targeting βCatenin in a PKAα-dependent manner
  publication-title: Cell Signal
– volume: 444
  start-page: 860
  year: 2006
  end-page: 867
  ident: bib0040
  article-title: Inflammation and metabolic disorders
  publication-title: Nature
– volume: 40
  start-page: 185
  year: 2004
  end-page: 194
  ident: bib0029
  article-title: Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway
  publication-title: Hepatology
– volume: 118
  start-page: 829
  year: 2008
  end-page: 838
  ident: bib0034
  article-title: Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
  publication-title: J Clin Invest
– volume: 7
  start-page: 4453
  year: 2015
  end-page: 4464
  ident: bib0080
  article-title: Low-density lipoprotein receptor-related protein 6 (LRP6) is a novel nutritional therapeutic target for hyperlipidemia, non-alcoholic fatty liver disease, and atherosclerosis
  publication-title: Nutrients
– volume: 167
  start-page: 1279
  year: 2005
  end-page: 1292
  ident: bib0067
  article-title: Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors
  publication-title: Am J Pathol
– volume: 64
  start-page: 73
  year: 2016
  end-page: 84
  ident: bib0005
  article-title: Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
  publication-title: Hepatology
– volume: 20
  start-page: 8393
  year: 2014
  end-page: 8406
  ident: bib0021
  article-title: Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease
  publication-title: World J Gastroenterol
– volume: 31
  start-page: 184
  year: 2015
  end-page: 191
  ident: bib0009
  article-title: Aging and liver disease
  publication-title: Curr Opin Gastroenterol
– volume: 51
  start-page: 511
  year: 2010
  end-page: 522
  ident: bib0047
  article-title: Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity
  publication-title: Hepatology
– volume: 337
  start-page: 98
  year: 2009
  end-page: 102
  ident: bib0014
  article-title: Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans
  publication-title: Am J Med Sci
– volume: 15
  year: 2020
  ident: bib0139
  article-title: Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs
  publication-title: PLoS One
– volume: 5
  start-page: e15521
  year: 2010
  ident: bib0127
  article-title: Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling
  publication-title: PLoS One
– volume: 131
  year: 2020
  ident: bib0135
  article-title: Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways
  publication-title: Biomed Pharmacother
– volume: 15
  start-page: s77
  year: 2015
  end-page: s82
  ident: bib0001
  article-title: An overview of the genetics, mechanisms and management of NAFLD and ALD
  publication-title: Clin Med (Lond)
– volume: 65
  start-page: 1038
  year: 2016
  end-page: 1048
  ident: bib0027
  article-title: The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
  publication-title: Metabolism
– volume: 33
  start-page: 325
  year: 2012
  end-page: 336
  ident: bib0108
  article-title: Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma
  publication-title: Tumour Biol
– volume: 40
  start-page: 1461
  year: 2008
  end-page: 1465
  ident: bib0010
  article-title: Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
  publication-title: Nat Genet
– volume: 581
  start-page: 2954
  year: 2007
  end-page: 2958
  ident: bib0092
  article-title: Wnt signaling enhances the activation and survival of human hepatic stellate cells
  publication-title: FEBS Lett
– volume: 45
  start-page: 401
  year: 2006
  end-page: 409
  ident: bib0099
  article-title: Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation
  publication-title: J Hepatol
– volume: 296
  start-page: G1248
  year: 2009
  end-page: G1257
  ident: bib0045
  article-title: Inflammasome-mediated regulation of hepatic stellate cells
  publication-title: Am J Physiol Gastrointest Liver Physiol
– volume: 280
  start-page: 4959
  year: 2005
  end-page: 4967
  ident: bib0098
  article-title: Adipogenic transcriptional regulation of hepatic stellate cells
  publication-title: J Biol Chem
– volume: 171
  start-page: 79
  year: 2008
  end-page: 88
  ident: bib0147
  article-title: Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin
  publication-title: Chem Biol Interact
– volume: 66
  start-page: 55
  year: 2017
  end-page: 63
  ident: bib0019
  article-title: Non-alcoholic fatty liver disease with and without metabolic syndrome: different long-term outcomes
  publication-title: Metabolism
– volume: 431
  start-page: 461
  year: 2004
  end-page: 466
  ident: bib0044
  article-title: NF-kappaB functions as a tumour promoter in inflammation-associated cancer
  publication-title: Nature
– volume: 136
  start-page: 133
  year: 2018
  end-page: 141
  ident: bib0153
  article-title: Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing NF-κB signaling and Wnt/β-catenin signaling
  publication-title: J Pharmacol Sci
– volume: 4
  start-page: ra6
  year: 2011
  ident: bib0082
  article-title: Wnt signaling regulates hepatic metabolism
  publication-title: Sci Signal
– volume: 10
  start-page: 330
  year: 2013
  end-page: 344
  ident: bib0022
  article-title: Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
  publication-title: Nat Rev Gastroenterol Hepatol
– volume: 67
  start-page: 91
  year: 2000
  end-page: 99
  ident: bib0146
  article-title: Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs
  publication-title: Life Sci
– volume: 21
  start-page: 44
  year: 2011
  end-page: 58
  ident: bib0070
  article-title: Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad
  publication-title: Semin Cancer Biol
– volume: 16
  start-page: 3797
  year: 1997
  end-page: 3804
  ident: bib0061
  article-title: Beta-catenin is a target for the ubiquitin-proteasome pathway
  publication-title: EMBO J
– volume: 75
  start-page: 1691
  year: 2015
  end-page: 1702
  ident: bib0142
  article-title: Wnt/β-catenin small-molecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stem-like cells
  publication-title: Cancer Res
– volume: 12
  start-page: 40
  year: 1999
  end-page: 79
  ident: bib0134
  article-title: Current and emerging azole antifungal agents
  publication-title: Clin Microbiol Rev
– volume: 131
  start-page: 1561
  year: 2006
  end-page: 1572
  ident: bib0068
  article-title: Conditional deletion of beta-catenin reveals its role in liver growth and regeneration
  publication-title: Gastroenterology
– volume: 44
  start-page: 57
  year: 2006
  end-page: 66
  ident: bib0051
  article-title: TGF-beta/Smad signaling in the injured liver
  publication-title: Z Gastroenterol
– volume: 28
  start-page: 321
  year: 2010
  end-page: 342
  ident: bib0046
  article-title: The sterile inflammatory response
  publication-title: Annu Rev Immunol
– volume: 51
  start-page: 371
  year: 2009
  end-page: 379
  ident: bib0008
  article-title: Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
  publication-title: J Hepatol
– volume: 65
  start-page: 1024
  year: 2016
  end-page: 1034
  ident: bib0113
  article-title: Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations
  publication-title: Gut
– volume: 25
  start-page: 195
  year: 2011
  end-page: 206
  ident: bib0055
  article-title: Mechanisms of hepatic fibrogenesis
  publication-title: Best Pract Res Clin Gastroenterol
– volume: 39
  start-page: 913
  year: 2019
  end-page: 919
  ident: bib0154
  article-title: Diwu Yanggan modulates the Wnt/β-catenin pathway and inhibits liver carcinogenesis signaling in 2-AAF/PH model rats
  publication-title: Curr Med Sci
– volume: 69
  start-page: S29
  year: 2016
  end-page: S30
  ident: bib0140
  article-title: Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC)
  publication-title: Eur J Cancer
– volume: 329
  start-page: 454
  year: 2010
  end-page: 457
  ident: bib0089
  article-title: Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity
  publication-title: Science
– volume: 8
  year: 2021
  ident: bib0104
  article-title: Sirt1 promotes the restoration of hepatic progenitor cell (HPC)-mediated liver fatty injury in NAFLD through activating the Wnt/β-catenin signal pathway
  publication-title: Front Nutr
– volume: 11
  year: 2016
  ident: bib0105
  article-title: Macrophage activation in pediatric nonalcoholic fatty liver disease (NAFLD) correlates with hepatic progenitor cell response via Wnt3a pathway
  publication-title: PLoS One
– volume: 94
  start-page: 2467
  year: 1999
  end-page: 2474
  ident: bib0003
  article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
  publication-title: Am J Gastroenterol
– volume: 284
  start-page: 16256
  year: 2009
  end-page: 16263
  ident: bib0122
  article-title: Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled
  publication-title: J Biol Chem
– volume: 9
  start-page: e83819
  year: 2014
  ident: bib0129
  article-title: Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression
  publication-title: PLoS One
– volume: 24
  start-page: 908
  year: 2018
  end-page: 922
  ident: bib0018
  article-title: Mechanisms of NAFLD development and therapeutic strategies
  publication-title: Nat Med
– volume: 131
  start-page: 411
  year: 2009
  end-page: 424
  ident: bib0075
  article-title: Knockdown of tight junction protein claudin-2 prevents bile canalicular formation in WIF-B9 cells
  publication-title: Histochem Cell Biol
– volume: 18
  start-page: 1745
  year: 2012
  end-page: 1752
  ident: bib0093
  article-title: Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays
  publication-title: World J Gastroenterol
– volume: 99
  start-page: 1497
  year: 2004
  end-page: 1502
  ident: bib0036
  article-title: Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis
  publication-title: Am J Gastroenterol
– volume: 9
  start-page: 2145
  year: 2014
  end-page: 2151
  ident: bib0094
  article-title: Zhu L. β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation
  publication-title: Mol Med Rep
– volume: 289
  start-page: 950
  year: 2000
  end-page: 953
  ident: bib0096
  article-title: Inhibition of adipogenesis by Wnt signaling
  publication-title: Science
– volume: 22
  start-page: 11
  year: 2018
  end-page: 21
  ident: bib0006
  article-title: The natural history of nonalcoholic fatty liver disease-an evolving view
  publication-title: Clin Liver Dis
– volume: 33
  start-page: 1098
  year: 2001
  end-page: 1109
  ident: bib0069
  article-title: Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration
  publication-title: Hepatology
– volume: 110
  start-page: 371
  year: 2019
  end-page: 379
  ident: bib0155
  article-title: Dendrobium candidum extract inhibits proliferation and induces apoptosis of liver cancer cells by inactivating Wnt/β-catenin signaling pathway
  publication-title: Biomed Pharmacother
– volume: 132
  start-page: 783
  year: 2013
  end-page: 792
  ident: bib0011
  article-title: Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan
  publication-title: Hum Genet
– volume: 74
  start-page: 193
  year: 1998
  end-page: 202
  ident: bib0058
  article-title: Liver cirrhosis
  publication-title: Postgrad Med J
– volume: 136
  year: 2020
  ident: bib0138
  article-title: The role of WNT/β-catenin signaling pathway and glutamine metabolism in the pathogenesis of CCl4-induced liver fibrosis: repositioning of niclosamide and concerns about lithium
  publication-title: Cytokine
– volume: 74
  start-page: 743
  year: 2003
  end-page: 756
  ident: bib0148
  article-title: Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock
  publication-title: Life Sci
– volume: 10
  year: 2015
  ident: bib0116
  article-title: Derricin and derricidin inhibit Wnt/β-catenin signaling and suppress colon cancer cell growth in vitro
  publication-title: PLoS One
– volume: 8
  start-page: 575
  year: 2018
  end-page: 586
  ident: bib0107
  article-title: Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway
  publication-title: Acta Pharm Sin B
– volume: 47
  start-page: 1018
  year: 2008
  end-page: 1031
  ident: bib0103
  article-title: Wnt2 acts as a cell type-specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway
  publication-title: Hepatology
– volume: 44
  start-page: 1167
  year: 2006
  end-page: 1174
  ident: bib0043
  article-title: Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
  publication-title: J Hepatol
– volume: 21
  start-page: 8293
  year: 2002
  end-page: 8301
  ident: bib0072
  article-title: New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism
  publication-title: Oncogene
– volume: 134
  start-page: 1655
  year: 2008
  end-page: 1669
  ident: bib0056
  article-title: Mechanisms of hepatic fibrogenesis
  publication-title: Gastroenterology
– volume: 148
  start-page: 1294
  year: 2015
  end-page: 1310
  ident: bib0060
  article-title: β-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis
  publication-title: Gastroenterology
– volume: 139
  start-page: 323
  year: 2010
  end-page: 334
  ident: bib0048
  article-title: Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice
  publication-title: Gastroenterology
– volume: 25
  start-page: 1653
  year: 2017
  end-page: 1664
  ident: bib0126
  article-title: Pharmacologic inhibition of β-catenin with pyrvinium inhibits murine and human models of Wilms tumor
  publication-title: Oncol Res
– volume: 15
  start-page: 45
  year: 2017
  ident: bib0035
  article-title: Non-alcoholic fatty liver disease
  publication-title: BMC Med
– volume: 92
  start-page: 103
  year: 1997
  end-page: 112
  ident: bib0059
  article-title: Pathogenesis of liver fibrosis
  publication-title: Clin Sci (Lond)
– volume: 26
  start-page: 650
  year: 2017
  end-page: 661
  ident: bib0115
  article-title: Modulating the wnt signaling pathway with small molecules
  publication-title: Protein Sci
– volume: 44
  start-page: 2201
  year: 2019
  end-page: 2212
  ident: bib0077
  article-title: Role and mechanisms of action of microRNA-21 as regards the regulation of the WNT/β-catenin signaling pathway in the pathogenesis of non-alcoholic fatty liver disease
  publication-title: Int J Mol Med
– volume: 279
  start-page: 32345
  year: 2004
  end-page: 32353
  ident: bib0088
  article-title: Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
  publication-title: J Biol Chem
– volume: 122
  start-page: 2871
  year: 2012
  end-page: 2883
  ident: bib0112
  article-title: Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
  publication-title: J Clin Invest
– volume: 44
  start-page: 2256
  year: 2019
  end-page: 2264
  ident: bib0132
  article-title: The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice
  publication-title: Int J Mol Med
– volume: 5
  start-page: 743
  year: 2010
  end-page: 749
  ident: bib0109
  article-title: SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma
  publication-title: Epigenetics
– volume: 48
  start-page: 249
  year: 2015
  end-page: 258
  ident: bib0124
  article-title: Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling
  publication-title: Cell Prolif
– volume: 59
  start-page: 2344
  year: 2014
  end-page: 2357
  ident: bib0071
  article-title: T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice
  publication-title: Hepatology
– volume: 13
  start-page: 511
  year: 2009
  end-page: 531
  ident: bib0012
  article-title: Epidemiology and natural history of non-alcoholic steatohepatitis
  publication-title: Clin Liver Dis
– volume: 29
  start-page: 3436
  year: 2015
  end-page: 3445
  ident: bib0086
  article-title: Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a
  publication-title: FASEB J
– volume: 287
  start-page: 7213
  year: 2012
  end-page: 7223
  ident: bib0079
  article-title: Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure
  publication-title: J Biol Chem
– volume: 294
  start-page: G39
  year: 2008
  end-page: G49
  ident: bib0091
  article-title: Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
  publication-title: Am J Physiol Gastrointest Liver Physiol
– volume: 11
  start-page: 183
  year: 2005
  end-page: 190
  ident: bib0041
  article-title: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB
  publication-title: Nat Med
– volume: 35
  start-page: 2197
  year: 2016
  end-page: 2207
  ident: bib0141
  article-title: Wnt addiction of genetically defined cancers reversed by PORCN inhibition
  publication-title: Oncogene
– volume: 58
  start-page: 1419
  year: 2009
  end-page: 1425
  ident: bib0013
  article-title: Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men
  publication-title: Gut
– volume: 2020
  year: 2020
  ident: bib0101
  article-title: Heme oxygenase-1 suppresses Wnt signaling pathway in nonalcoholic steatohepatitis-related liver fibrosis
  publication-title: Biomed Res Int
– volume: 42
  start-page: 928
  year: 2005
  end-page: 940
  ident: bib0037
  article-title: NASH: a mitochondrial disease
  publication-title: J Hepatol
– volume: 226
  start-page: 2438
  year: 2011
  end-page: 2447
  ident: bib0130
  article-title: CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver
  publication-title: J Cell Physiol
– volume: 18
  start-page: 25
  year: 2013
  end-page: 26
  ident: bib0131
  article-title: CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study
  publication-title: Oncologist
– volume: 26
  start-page: 100
  year: 2014
  end-page: 107
  ident: bib0057
  article-title: Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer
  publication-title: Curr Opin Oncol
– volume: 75
  start-page: 1428
  year: 2010
  end-page: 1434
  ident: bib0063
  article-title: The Wnt/Frizzled GPCR signaling pathway
  publication-title: Biochemistry
– volume: 162
  start-page: 496
  year: 2013
  end-page: 500
  ident: bib0024
  article-title: Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010
  publication-title: J Pediatr
– volume: 6
  start-page: 1
  year: 2006
  end-page: 28
  ident: bib0038
  article-title: Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it
  publication-title: Mitochondrion
– volume: 44
  start-page: 15495
  year: 2005
  end-page: 15503
  ident: bib0121
  article-title: Identification of a specific inhibitor of the dishevelled PDZ domain
  publication-title: Biochemistry
– volume: 407
  start-page: 535
  year: 2000
  end-page: 538
  ident: bib0062
  article-title: An LDL-receptor-related protein mediates Wnt signalling in mice
  publication-title: Nature
– volume: 45
  start-page: 195
  year: 2007
  end-page: 204
  ident: bib0102
  article-title: Wnt'er in liver: expression of Wnt and frizzled genes in mouse
  publication-title: Hepatology
– volume: 5
  start-page: 997
  year: 2006
  end-page: 1014
  ident: bib0106
  article-title: Mining the Wnt pathway for cancer therapeutics
  publication-title: Nat Rev Drug Discov
– volume: 245
  start-page: 1504
  year: 2020
  end-page: 1512
  ident: bib0052
  article-title: Endothelin-1 in portal hypertension: the intricate role of hepatic stellate cells
  publication-title: Exp Biol Med
– volume: 71
  start-page: 4028
  year: 2011
  end-page: 4039
  ident: bib0110
  article-title: EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis
  publication-title: Cancer Res
– volume: 24
  start-page: 2974
  year: 2018
  end-page: 2983
  ident: bib0025
  article-title: Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model"
  publication-title: World J Gastroenterol
– volume: 111
  start-page: 1645
  year: 1996
  end-page: 1653
  ident: bib0039
  article-title: Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
  publication-title: Gastroenterology
– volume: 7
  start-page: 682
  year: 2010
  end-page: 690
  ident: bib0053
  article-title: Functional role of chemokines in liver disease models
  publication-title: Nat Rev Gastroenterol Hepatol
– volume: 55
  start-page: 415
  year: 2006
  end-page: 424
  ident: bib0042
  article-title: Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice
  publication-title: Gut
– volume: 330
  start-page: 505
  year: 2005
  end-page: 510
  ident: bib0145
  article-title: Wnt5b partially inhibits canonical Wnt/beta-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes
  publication-title: Biochem Biophys Res Commun
– volume: 62
  start-page: S47
  year: 2015
  end-page: S64
  ident: bib0007
  article-title: NAFLD: a multisystem disease
  publication-title: J Hepatol
– volume: 15
  start-page: 11
  year: 2018
  end-page: 20
  ident: bib0004
  article-title: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
  publication-title: Nat Rev Gastroenterol Hepatol
– volume: 75
  start-page: 4803
  year: 2015
  end-page: 4816
  ident: bib0111
  article-title: Histone deacetylase HDAC8 promotes insulin resistance and β-catenin activation in NAFLD-associated hepatocellular carcinoma
  publication-title: Cancer Res
– volume: 1864
  start-page: 804
  year: 2018
  end-page: 818
  ident: bib0144
  article-title: Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis
  publication-title: Biochim Biophys Acta Mol Basis Dis
– volume: 109
  start-page: 11717
  year: 2012
  end-page: 11722
  ident: bib0118
  article-title: Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
  publication-title: Proc Natl Acad Sci U S A
– volume: 142
  start-page: 687
  year: 2010
  end-page: 698
  ident: bib0136
  article-title: GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects
  publication-title: Cell
– volume: 277
  start-page: 210
  year: 2014
  end-page: 220
  ident: bib0149
  article-title: Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/β-catenin signaling
  publication-title: Toxicol Appl Pharmacol
– volume: 163
  start-page: 1301
  year: 2003
  end-page: 1311
  ident: bib0032
  article-title: Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease
  publication-title: Am J Pathol
– volume: 18
  start-page: 4233
  year: 1999
  end-page: 4240
  ident: bib0065
  article-title: Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1
  publication-title: EMBO J
– volume: 22
  start-page: 10512
  year: 2016
  end-page: 10522
  ident: bib0049
  article-title: Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets
  publication-title: World J Gastroenterol
– volume: 343
  start-page: d3897
  year: 2011
  ident: bib0002
  article-title: How big a problem is non-alcoholic fatty liver disease?
  publication-title: BMJ
– volume: 16
  start-page: 4243
  year: 2010
  end-page: 4252
  ident: bib0015
  article-title: Obstructive sleep apnea syndrome and fatty liver: association or causal link?
  publication-title: World J Gastroenterol
– volume: 53
  start-page: 372
  year: 2010
  end-page: 384
  ident: bib0033
  article-title: A position statement on NAFLD/NASH based on the EASL 2009 special conference
  publication-title: J Hepatol
– volume: 2
  start-page: 231
  year: 2009
  end-page: 237
  ident: bib0017
  article-title: A comprehensive definition for metabolic syndrome
  publication-title: Dis Model Mech
– volume: 98
  start-page: E60
  year: 2013
  end-page: E65
  ident: bib0081
  article-title: Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes
  publication-title: J Clin Endocrinol Metab
– volume: 47
  start-page: 1067
  year: 2009
  end-page: 1074
  ident: bib0023
  article-title: SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats
  publication-title: Free Radic Biol Med
– volume: 7
  start-page: 77707
  year: 2016
  end-page: 77720
  ident: bib0078
  article-title: SIRT1 suppresses adipogenesis by activating Wnt/β-catenin signaling
  publication-title: Oncotarget
– volume: 8
  start-page: e81710
  year: 2013
  ident: bib0120
  article-title: Mutational analysis of sclerostin shows importance of the flexible loop and the cystine-knot for Wnt-signaling inhibition
  publication-title: PLoS One
– volume: 15
  start-page: 3
  year: 2018
  end-page: 13
  ident: bib0076
  article-title: Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases
  publication-title: Diab Vasc Dis Res
– volume: 13
  start-page: 4705
  year: 2016
  end-page: 4714
  ident: bib0152
  article-title: Herbal medicine Gan-fu-kang downregulates Wnt/Ca2+ signaling to attenuate liver fibrogenesis
  publication-title: Mol Med Rep
– volume: 52
  start-page: 1410
  year: 2010
  end-page: 1419
  ident: bib0074
  article-title: Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis
  publication-title: Hepatology
– volume: 28
  start-page: 370
  year: 2008
  end-page: 379
  ident: bib0031
  article-title: Mechanisms of disease progression in nonalcoholic fatty liver disease
  publication-title: Semin Liver Dis
– volume: 176
  start-page: 744
  year: 2010
  end-page: 753
  ident: bib0087
  article-title: Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis
  publication-title: Am J Pathol
– volume: 108
  start-page: 12752
  year: 2011
  ident: 10.1016/j.hbpd.2022.10.003_bib0064
  article-title: Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1006437108
– volume: 48
  start-page: 249
  year: 2015
  ident: 10.1016/j.hbpd.2022.10.003_bib0124
  article-title: Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling
  publication-title: Cell Prolif
  doi: 10.1111/cpr.12161
– volume: 407
  start-page: 535
  year: 2000
  ident: 10.1016/j.hbpd.2022.10.003_bib0062
  article-title: An LDL-receptor-related protein mediates Wnt signalling in mice
  publication-title: Nature
  doi: 10.1038/35035124
– volume: 7
  start-page: 77707
  year: 2016
  ident: 10.1016/j.hbpd.2022.10.003_bib0078
  article-title: SIRT1 suppresses adipogenesis by activating Wnt/β-catenin signaling in vivo and in vitro
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.12774
– volume: 109
  start-page: 11402
  year: 2012
  ident: 10.1016/j.hbpd.2022.10.003_bib0085
  article-title: Chemical and genetic evidence for the involvement of Wnt antagonist Dickkopf2 in regulation of glucose metabolism
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1205015109
– volume: 98
  start-page: E60
  year: 2013
  ident: 10.1016/j.hbpd.2022.10.003_bib0081
  article-title: Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2012-3038
– volume: 136
  year: 2020
  ident: 10.1016/j.hbpd.2022.10.003_bib0138
  article-title: The role of WNT/β-catenin signaling pathway and glutamine metabolism in the pathogenesis of CCl4-induced liver fibrosis: repositioning of niclosamide and concerns about lithium
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2020.155250
– volume: 9
  start-page: 208
  year: 2009
  ident: 10.1016/j.hbpd.2022.10.003_bib0083
  article-title: The role of FOXO in the regulation of metabolism
  publication-title: Curr Diab Rep
  doi: 10.1007/s11892-009-0034-5
– volume: 28
  start-page: 321
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0046
  article-title: The sterile inflammatory response
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-030409-101311
– volume: 7
  start-page: 682
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0053
  article-title: Functional role of chemokines in liver disease models
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2010.168
– volume: 109
  start-page: 11717
  year: 2012
  ident: 10.1016/j.hbpd.2022.10.003_bib0118
  article-title: Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1120068109
– volume: 62
  start-page: 1787
  year: 2013
  ident: 10.1016/j.hbpd.2022.10.003_bib0016
  article-title: Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
  publication-title: Gut
  doi: 10.1136/gutjnl-2012-303816
– volume: 40
  start-page: 185
  year: 2004
  ident: 10.1016/j.hbpd.2022.10.003_bib0029
  article-title: Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway
  publication-title: Hepatology
  doi: 10.1002/hep.20283
– volume: 122
  start-page: 2871
  year: 2012
  ident: 10.1016/j.hbpd.2022.10.003_bib0112
  article-title: Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
  publication-title: J Clin Invest
  doi: 10.1172/JCI63539
– volume: 343
  start-page: d3897
  year: 2011
  ident: 10.1016/j.hbpd.2022.10.003_bib0002
  article-title: How big a problem is non-alcoholic fatty liver disease?
  publication-title: BMJ
  doi: 10.1136/bmj.d3897
– volume: 3
  start-page: 680
  year: 2012
  ident: 10.1016/j.hbpd.2022.10.003_bib0117
  article-title: An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid
  publication-title: Nat Commun
  doi: 10.1038/ncomms1680
– volume: 33
  start-page: 1098
  year: 2001
  ident: 10.1016/j.hbpd.2022.10.003_bib0069
  article-title: Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration
  publication-title: Hepatology
  doi: 10.1053/jhep.2001.23786
– volume: 47
  start-page: 1067
  year: 2009
  ident: 10.1016/j.hbpd.2022.10.003_bib0023
  article-title: SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2009.07.016
– volume: 15
  start-page: s77
  year: 2015
  ident: 10.1016/j.hbpd.2022.10.003_bib0001
  article-title: An overview of the genetics, mechanisms and management of NAFLD and ALD
  publication-title: Clin Med (Lond)
  doi: 10.7861/clinmedicine.15-6-s77
– volume: 29
  start-page: 3436
  year: 2015
  ident: 10.1016/j.hbpd.2022.10.003_bib0086
  article-title: Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a
  publication-title: FASEB J
  doi: 10.1096/fj.15-271171
– volume: 329
  start-page: 454
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0089
  article-title: Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity
  publication-title: Science
  doi: 10.1126/science.1188280
– volume: 142
  start-page: 687
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0136
  article-title: GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects
  publication-title: Cell
  doi: 10.1016/j.cell.2010.07.041
– volume: 10
  year: 2015
  ident: 10.1016/j.hbpd.2022.10.003_bib0116
  article-title: Derricin and derricidin inhibit Wnt/β-catenin signaling and suppress colon cancer cell growth in vitro
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0120919
– volume: 28
  start-page: 370
  year: 2008
  ident: 10.1016/j.hbpd.2022.10.003_bib0031
  article-title: Mechanisms of disease progression in nonalcoholic fatty liver disease
  publication-title: Semin Liver Dis
  doi: 10.1055/s-0028-1091981
– volume: 75
  start-page: 1428
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0063
  article-title: The Wnt/Frizzled GPCR signaling pathway
  publication-title: Biochemistry
– volume: 330
  start-page: 505
  year: 2005
  ident: 10.1016/j.hbpd.2022.10.003_bib0145
  article-title: Wnt5b partially inhibits canonical Wnt/beta-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2005.03.007
– volume: 431
  start-page: 461
  year: 2004
  ident: 10.1016/j.hbpd.2022.10.003_bib0044
  article-title: NF-kappaB functions as a tumour promoter in inflammation-associated cancer
  publication-title: Nature
  doi: 10.1038/nature02924
– volume: 171
  start-page: 79
  year: 2008
  ident: 10.1016/j.hbpd.2022.10.003_bib0147
  article-title: Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin
  publication-title: Chem Biol Interact
  doi: 10.1016/j.cbi.2007.09.003
– volume: 26
  start-page: 650
  year: 2017
  ident: 10.1016/j.hbpd.2022.10.003_bib0115
  article-title: Modulating the wnt signaling pathway with small molecules
  publication-title: Protein Sci
  doi: 10.1002/pro.3122
– volume: 44
  start-page: 1167
  year: 2006
  ident: 10.1016/j.hbpd.2022.10.003_bib0043
  article-title: Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2006.02.011
– volume: 22
  start-page: 11
  year: 2018
  ident: 10.1016/j.hbpd.2022.10.003_bib0006
  article-title: The natural history of nonalcoholic fatty liver disease-an evolving view
  publication-title: Clin Liver Dis
  doi: 10.1016/j.cld.2017.08.003
– volume: 45
  start-page: 401
  year: 2006
  ident: 10.1016/j.hbpd.2022.10.003_bib0099
  article-title: Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2006.03.016
– volume: 15
  start-page: 3
  year: 2018
  ident: 10.1016/j.hbpd.2022.10.003_bib0076
  article-title: Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases
  publication-title: Diab Vasc Dis Res
  doi: 10.1177/1479164117738442
– volume: 62
  start-page: S47
  year: 2015
  ident: 10.1016/j.hbpd.2022.10.003_bib0007
  article-title: NAFLD: a multisystem disease
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2014.12.012
– volume: 33
  start-page: 325
  year: 2012
  ident: 10.1016/j.hbpd.2022.10.003_bib0108
  article-title: Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma
  publication-title: Tumour Biol
  doi: 10.1007/s13277-012-0331-5
– volume: 52
  start-page: 1410
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0074
  article-title: Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis
  publication-title: Hepatology
  doi: 10.1002/hep.23801
– volume: 5
  start-page: 997
  year: 2006
  ident: 10.1016/j.hbpd.2022.10.003_bib0106
  article-title: Mining the Wnt pathway for cancer therapeutics
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd2154
– volume: 10
  start-page: 237
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0020
  article-title: Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey
  publication-title: BMC Public Health
  doi: 10.1186/1471-2458-10-237
– volume: 76
  start-page: 891
  year: 2016
  ident: 10.1016/j.hbpd.2022.10.003_bib0143
  article-title: A small-molecule antagonist of the β-catenin/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-15-1519
– volume: 15
  start-page: 45
  year: 2017
  ident: 10.1016/j.hbpd.2022.10.003_bib0035
  article-title: Non-alcoholic fatty liver disease
  publication-title: BMC Med
  doi: 10.1186/s12916-017-0806-8
– volume: 26
  start-page: 94
  year: 2014
  ident: 10.1016/j.hbpd.2022.10.003_bib0119
  article-title: Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signaling
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2013.09.016
– volume: 8
  start-page: 282
  year: 2014
  ident: 10.1016/j.hbpd.2022.10.003_bib0095
  article-title: Mest attenuates CCl4-induced liver fibrosis in rats by inhibiting the Wnt/β-catenin signaling pathway
  publication-title: Gut Liver
  doi: 10.5009/gnl.2014.8.3.282
– volume: 31
  start-page: 184
  year: 2015
  ident: 10.1016/j.hbpd.2022.10.003_bib0009
  article-title: Aging and liver disease
  publication-title: Curr Opin Gastroenterol
  doi: 10.1097/MOG.0000000000000176
– volume: 16
  start-page: 3797
  year: 1997
  ident: 10.1016/j.hbpd.2022.10.003_bib0061
  article-title: Beta-catenin is a target for the ubiquitin-proteasome pathway
  publication-title: EMBO J
  doi: 10.1093/emboj/16.13.3797
– volume: 7
  start-page: 4453
  year: 2015
  ident: 10.1016/j.hbpd.2022.10.003_bib0080
  article-title: Low-density lipoprotein receptor-related protein 6 (LRP6) is a novel nutritional therapeutic target for hyperlipidemia, non-alcoholic fatty liver disease, and atherosclerosis
  publication-title: Nutrients
  doi: 10.3390/nu7064453
– volume: 337
  start-page: 98
  year: 2009
  ident: 10.1016/j.hbpd.2022.10.003_bib0014
  article-title: Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans
  publication-title: Am J Med Sci
  doi: 10.1097/MAJ.0b013e3181812879
– volume: 9
  start-page: 367
  year: 2008
  ident: 10.1016/j.hbpd.2022.10.003_bib0030
  article-title: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm2391
– volume: 74
  start-page: 193
  year: 1998
  ident: 10.1016/j.hbpd.2022.10.003_bib0058
  article-title: Liver cirrhosis
  publication-title: Postgrad Med J
  doi: 10.1136/pgmj.74.870.193
– volume: 126
  start-page: 1134
  year: 2004
  ident: 10.1016/j.hbpd.2022.10.003_bib0066
  article-title: Beta-catenin is temporally regulated during normal liver development
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2003.12.047
– volume: 71
  start-page: 4028
  year: 2011
  ident: 10.1016/j.hbpd.2022.10.003_bib0110
  article-title: EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-3342
– volume: 131
  year: 2020
  ident: 10.1016/j.hbpd.2022.10.003_bib0135
  article-title: Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2020.110661
– volume: 289
  start-page: 950
  year: 2000
  ident: 10.1016/j.hbpd.2022.10.003_bib0096
  article-title: Inhibition of adipogenesis by Wnt signaling
  publication-title: Science
  doi: 10.1126/science.289.5481.950
– volume: 79
  start-page: 376
  year: 2012
  ident: 10.1016/j.hbpd.2022.10.003_bib0123
  article-title: Synthesis of potent dishevelled PDZ domain inhibitors guided by virtual screening and NMR studies
  publication-title: Chem Biol Drug Des
  doi: 10.1111/j.1747-0285.2011.01295.x
– volume: 20
  start-page: 8393
  year: 2014
  ident: 10.1016/j.hbpd.2022.10.003_bib0021
  article-title: Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v20.i26.8393
– volume: 59
  start-page: 2344
  year: 2014
  ident: 10.1016/j.hbpd.2022.10.003_bib0071
  article-title: T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice
  publication-title: Hepatology
  doi: 10.1002/hep.26924
– volume: 25
  start-page: 195
  year: 2011
  ident: 10.1016/j.hbpd.2022.10.003_bib0055
  article-title: Mechanisms of hepatic fibrogenesis
  publication-title: Best Pract Res Clin Gastroenterol
  doi: 10.1016/j.bpg.2011.02.005
– volume: 132
  start-page: 783
  year: 2013
  ident: 10.1016/j.hbpd.2022.10.003_bib0011
  article-title: Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan
  publication-title: Hum Genet
  doi: 10.1007/s00439-013-1294-3
– volume: 131
  start-page: 1561
  year: 2006
  ident: 10.1016/j.hbpd.2022.10.003_bib0068
  article-title: Conditional deletion of beta-catenin reveals its role in liver growth and regeneration
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2006.08.042
– volume: 13
  start-page: 4705
  year: 2016
  ident: 10.1016/j.hbpd.2022.10.003_bib0152
  article-title: Herbal medicine Gan-fu-kang downregulates Wnt/Ca2+ signaling to attenuate liver fibrogenesis in vitro and in vivo
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2016.5148
– volume: 24
  start-page: 908
  year: 2018
  ident: 10.1016/j.hbpd.2022.10.003_bib0018
  article-title: Mechanisms of NAFLD development and therapeutic strategies
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0104-9
– volume: 237
  start-page: 436
  year: 2022
  ident: 10.1016/j.hbpd.2022.10.003_bib0050
  article-title: Hepatic stellate cells in the injured liver: perspectives beyond hepatic fibrosis
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.30582
– volume: 44
  start-page: 57
  year: 2006
  ident: 10.1016/j.hbpd.2022.10.003_bib0051
  article-title: TGF-beta/Smad signaling in the injured liver
  publication-title: Z Gastroenterol
  doi: 10.1055/s-2005-858989
– volume: 226
  start-page: 2438
  year: 2011
  ident: 10.1016/j.hbpd.2022.10.003_bib0130
  article-title: CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.22593
– volume: 92
  start-page: 103
  year: 1997
  ident: 10.1016/j.hbpd.2022.10.003_bib0059
  article-title: Pathogenesis of liver fibrosis
  publication-title: Clin Sci (Lond)
  doi: 10.1042/cs0920103
– volume: 5
  start-page: e15521
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0127
  article-title: Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0015521
– volume: 279
  start-page: 32345
  year: 2004
  ident: 10.1016/j.hbpd.2022.10.003_bib0088
  article-title: Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M313478200
– volume: 8
  start-page: 575
  year: 2018
  ident: 10.1016/j.hbpd.2022.10.003_bib0107
  article-title: Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway
  publication-title: Acta Pharm Sin B
  doi: 10.1016/j.apsb.2017.10.003
– volume: 65
  start-page: 1038
  year: 2016
  ident: 10.1016/j.hbpd.2022.10.003_bib0027
  article-title: The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2015.12.012
– volume: 6
  start-page: 1
  year: 2006
  ident: 10.1016/j.hbpd.2022.10.003_bib0038
  article-title: Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it
  publication-title: Mitochondrion
  doi: 10.1016/j.mito.2005.10.004
– volume: 114
  start-page: 842
  year: 1998
  ident: 10.1016/j.hbpd.2022.10.003_bib0026
  article-title: Steatohepatitis: a tale of two "hits"?
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(98)70599-2
– volume: 374
  start-page: 13
  year: 2013
  ident: 10.1016/j.hbpd.2022.10.003_bib0100
  article-title: Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through promoting the ROS production
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-012-1498-1
– volume: 287
  start-page: 187
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0150
  article-title: Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2009.06.009
– volume: 69
  start-page: S29
  year: 2016
  ident: 10.1016/j.hbpd.2022.10.003_bib0140
  article-title: Initial results from a phase 1a/b study of OMP-131R10, a first-in-class anti-RSPO3 antibody, in advanced solid tumors and previously treated metastatic colorectal cancer (CRC)
  publication-title: Eur J Cancer
  doi: 10.1016/S0959-8049(16)32668-5
– volume: 16
  start-page: 1941
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0028
  article-title: Insulin resistance in nonalcoholic fatty liver disease
  publication-title: Curr Pharm Des
  doi: 10.2174/138161210791208875
– volume: 8
  year: 2021
  ident: 10.1016/j.hbpd.2022.10.003_bib0104
  article-title: Sirt1 promotes the restoration of hepatic progenitor cell (HPC)-mediated liver fatty injury in NAFLD through activating the Wnt/β-catenin signal pathway
  publication-title: Front Nutr
  doi: 10.3389/fnut.2021.791861
– volume: 21
  start-page: 44
  year: 2011
  ident: 10.1016/j.hbpd.2022.10.003_bib0070
  article-title: Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2010.12.010
– volume: 25
  start-page: 1653
  year: 2017
  ident: 10.1016/j.hbpd.2022.10.003_bib0126
  article-title: Pharmacologic inhibition of β-catenin with pyrvinium inhibits murine and human models of Wilms tumor
  publication-title: Oncol Res
  doi: 10.3727/096504017X14992942781895
– volume: 24
  start-page: 2974
  year: 2018
  ident: 10.1016/j.hbpd.2022.10.003_bib0025
  article-title: Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model"
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v24.i27.2974
– volume: 162
  start-page: 496
  year: 2013
  ident: 10.1016/j.hbpd.2022.10.003_bib0024
  article-title: Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2012.08.043
– volume: 16
  start-page: 4243
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0015
  article-title: Obstructive sleep apnea syndrome and fatty liver: association or causal link?
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v16.i34.4243
– volume: 26
  start-page: 100
  year: 2014
  ident: 10.1016/j.hbpd.2022.10.003_bib0057
  article-title: Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer
  publication-title: Curr Opin Oncol
  doi: 10.1097/CCO.0000000000000042
– volume: 64
  start-page: 73
  year: 2016
  ident: 10.1016/j.hbpd.2022.10.003_bib0005
  article-title: Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
  publication-title: Hepatology
  doi: 10.1002/hep.28431
– volume: 51
  start-page: 371
  year: 2009
  ident: 10.1016/j.hbpd.2022.10.003_bib0008
  article-title: Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2009.03.019
– volume: 245
  start-page: 1504
  year: 2020
  ident: 10.1016/j.hbpd.2022.10.003_bib0052
  article-title: Endothelin-1 in portal hypertension: the intricate role of hepatic stellate cells
  publication-title: Exp Biol Med
  doi: 10.1177/1535370220949148
– volume: 65
  start-page: 1024
  year: 2016
  ident: 10.1016/j.hbpd.2022.10.003_bib0113
  article-title: Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations
  publication-title: Gut
  doi: 10.1136/gutjnl-2014-308969
– volume: 8
  start-page: e81710
  year: 2013
  ident: 10.1016/j.hbpd.2022.10.003_bib0120
  article-title: Mutational analysis of sclerostin shows importance of the flexible loop and the cystine-knot for Wnt-signaling inhibition
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0081710
– volume: 37
  start-page: 62
  year: 2017
  ident: 10.1016/j.hbpd.2022.10.003_bib0114
  article-title: Sirt1 suppresses Wnt/βCatenin signaling in liver cancer cells by targeting βCatenin in a PKAα-dependent manner
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2017.06.001
– volume: 18
  start-page: 25
  year: 2013
  ident: 10.1016/j.hbpd.2022.10.003_bib0131
  article-title: CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation study
  publication-title: Oncologist
  doi: 10.1634/theoncologist.2012-0211
– volume: 58
  start-page: 1419
  year: 2009
  ident: 10.1016/j.hbpd.2022.10.003_bib0013
  article-title: Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men
  publication-title: Gut
  doi: 10.1136/gut.2008.161885
– volume: 38
  start-page: 320
  year: 2006
  ident: 10.1016/j.hbpd.2022.10.003_bib0084
  article-title: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
  publication-title: Nat Genet
  doi: 10.1038/ng1732
– volume: 44
  start-page: 2201
  year: 2019
  ident: 10.1016/j.hbpd.2022.10.003_bib0077
  article-title: Role and mechanisms of action of microRNA-21 as regards the regulation of the WNT/β-catenin signaling pathway in the pathogenesis of non-alcoholic fatty liver disease
  publication-title: Int J Mol Med
– volume: 11
  year: 2016
  ident: 10.1016/j.hbpd.2022.10.003_bib0105
  article-title: Macrophage activation in pediatric nonalcoholic fatty liver disease (NAFLD) correlates with hepatic progenitor cell response via Wnt3a pathway
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0157246
– volume: 280
  start-page: 4959
  year: 2005
  ident: 10.1016/j.hbpd.2022.10.003_bib0098
  article-title: Adipogenic transcriptional regulation of hepatic stellate cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M410078200
– volume: 111
  start-page: 1645
  year: 1996
  ident: 10.1016/j.hbpd.2022.10.003_bib0039
  article-title: Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
  publication-title: Gastroenterology
  doi: 10.1016/S0016-5085(96)70028-8
– volume: 42
  start-page: 928
  year: 2005
  ident: 10.1016/j.hbpd.2022.10.003_bib0037
  article-title: NASH: a mitochondrial disease
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2005.03.004
– volume: 167
  start-page: 1279
  year: 2005
  ident: 10.1016/j.hbpd.2022.10.003_bib0067
  article-title: Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)61215-1
– volume: 43
  start-page: 817
  year: 2006
  ident: 10.1016/j.hbpd.2022.10.003_bib0073
  article-title: Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice
  publication-title: Hepatology
  doi: 10.1002/hep.21131
– volume: 45
  start-page: 195
  year: 2007
  ident: 10.1016/j.hbpd.2022.10.003_bib0102
  article-title: Wnt'er in liver: expression of Wnt and frizzled genes in mouse
  publication-title: Hepatology
  doi: 10.1002/hep.21473
– volume: 94
  start-page: 2467
  year: 1999
  ident: 10.1016/j.hbpd.2022.10.003_bib0003
  article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.1999.01377.x
– volume: 294
  start-page: G39
  year: 2008
  ident: 10.1016/j.hbpd.2022.10.003_bib0091
  article-title: Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00263.2007
– volume: 163
  start-page: 1301
  year: 2003
  ident: 10.1016/j.hbpd.2022.10.003_bib0032
  article-title: Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63489-X
– volume: 20
  start-page: 1263
  year: 2014
  ident: 10.1016/j.hbpd.2022.10.003_bib0137
  article-title: Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice
  publication-title: Nat Med
  doi: 10.1038/nm.3699
– volume: 12
  start-page: 40
  year: 1999
  ident: 10.1016/j.hbpd.2022.10.003_bib0134
  article-title: Current and emerging azole antifungal agents
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.12.1.40
– volume: 287
  start-page: 7213
  year: 2012
  ident: 10.1016/j.hbpd.2022.10.003_bib0079
  article-title: Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M111.286724
– volume: 18
  start-page: 4233
  year: 1999
  ident: 10.1016/j.hbpd.2022.10.003_bib0065
  article-title: Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1
  publication-title: EMBO J
  doi: 10.1093/emboj/18.15.4233
– volume: 18
  start-page: 1745
  year: 2012
  ident: 10.1016/j.hbpd.2022.10.003_bib0093
  article-title: Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v18.i15.1745
– volume: 55
  start-page: 415
  year: 2006
  ident: 10.1016/j.hbpd.2022.10.003_bib0042
  article-title: Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice
  publication-title: Gut
  doi: 10.1136/gut.2005.071118
– volume: 4
  start-page: ra6
  year: 2011
  ident: 10.1016/j.hbpd.2022.10.003_bib0082
  article-title: Wnt signaling regulates hepatic metabolism
  publication-title: Sci Signal
  doi: 10.1126/scisignal.2001249
– volume: 12
  start-page: 1848
  year: 2013
  ident: 10.1016/j.hbpd.2022.10.003_bib0125
  article-title: Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-13-0048
– volume: 37
  start-page: 7
  year: 2018
  ident: 10.1016/j.hbpd.2022.10.003_bib0151
  article-title: The plant alkaloid tetrandrine inhibits metastasis via autophagy-dependent Wnt/β-catenin and metastatic tumor antigen 1 signaling in human liver cancer cells
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-018-0678-6
– volume: 44
  start-page: 2256
  year: 2019
  ident: 10.1016/j.hbpd.2022.10.003_bib0132
  article-title: The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice
  publication-title: Int J Mol Med
– volume: 67
  start-page: 91
  year: 2000
  ident: 10.1016/j.hbpd.2022.10.003_bib0146
  article-title: Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs
  publication-title: Life Sci
  doi: 10.1016/S0024-3205(00)00605-6
– volume: 581
  start-page: 2954
  year: 2007
  ident: 10.1016/j.hbpd.2022.10.003_bib0092
  article-title: Wnt signaling enhances the activation and survival of human hepatic stellate cells
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2007.05.050
– volume: 35
  start-page: 2197
  year: 2016
  ident: 10.1016/j.hbpd.2022.10.003_bib0141
  article-title: Wnt addiction of genetically defined cancers reversed by PORCN inhibition
  publication-title: Oncogene
  doi: 10.1038/onc.2015.280
– volume: 5
  start-page: 743
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0109
  article-title: SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma
  publication-title: Epigenetics
  doi: 10.4161/epi.5.8.13104
– volume: 148
  start-page: 1294
  year: 2015
  ident: 10.1016/j.hbpd.2022.10.003_bib0060
  article-title: β-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2015.02.056
– volume: 118
  start-page: 829
  year: 2008
  ident: 10.1016/j.hbpd.2022.10.003_bib0034
  article-title: Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
  publication-title: J Clin Invest
  doi: 10.1172/JCI34275
– volume: 279
  start-page: 11392
  year: 2004
  ident: 10.1016/j.hbpd.2022.10.003_bib0097
  article-title: Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M310284200
– volume: 47
  start-page: 1018
  year: 2008
  ident: 10.1016/j.hbpd.2022.10.003_bib0103
  article-title: Wnt2 acts as a cell type-specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway
  publication-title: Hepatology
  doi: 10.1002/hep.22084
– volume: 15
  year: 2020
  ident: 10.1016/j.hbpd.2022.10.003_bib0139
  article-title: Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs
  publication-title: PLoS One
– volume: 17
  start-page: 89
  year: 2001
  ident: 10.1016/j.hbpd.2022.10.003_bib0090
  article-title: Genomic analysis of differentially expressed genes in liver and biliary epithelial cells of patients with primary biliary cirrhosis
  publication-title: J Autoimmun
  doi: 10.1006/jaut.2001.0522
– volume: 39
  start-page: 913
  year: 2019
  ident: 10.1016/j.hbpd.2022.10.003_bib0154
  article-title: Diwu Yanggan modulates the Wnt/β-catenin pathway and inhibits liver carcinogenesis signaling in 2-AAF/PH model rats
  publication-title: Curr Med Sci
  doi: 10.1007/s11596-019-2123-2
– volume: 9
  start-page: 2145
  year: 2014
  ident: 10.1016/j.hbpd.2022.10.003_bib0094
  article-title: Zhu L. β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2014.2099
– volume: 21
  start-page: 8293
  year: 2002
  ident: 10.1016/j.hbpd.2022.10.003_bib0072
  article-title: New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1206118
– volume: 9
  start-page: e83819
  year: 2014
  ident: 10.1016/j.hbpd.2022.10.003_bib0129
  article-title: Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0083819
– volume: 284
  start-page: 16256
  year: 2009
  ident: 10.1016/j.hbpd.2022.10.003_bib0122
  article-title: Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M109.009647
– volume: 22
  start-page: 10512
  year: 2016
  ident: 10.1016/j.hbpd.2022.10.003_bib0049
  article-title: Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v22.i48.10512
– volume: 444
  start-page: 860
  year: 2006
  ident: 10.1016/j.hbpd.2022.10.003_bib0040
  article-title: Inflammation and metabolic disorders
  publication-title: Nature
  doi: 10.1038/nature05485
– volume: 44
  start-page: 15495
  year: 2005
  ident: 10.1016/j.hbpd.2022.10.003_bib0121
  article-title: Identification of a specific inhibitor of the dishevelled PDZ domain
  publication-title: Biochemistry
  doi: 10.1021/bi0512602
– volume: 2
  start-page: 231
  year: 2009
  ident: 10.1016/j.hbpd.2022.10.003_bib0017
  article-title: A comprehensive definition for metabolic syndrome
  publication-title: Dis Model Mech
  doi: 10.1242/dmm.001180
– volume: 10
  start-page: 330
  year: 2013
  ident: 10.1016/j.hbpd.2022.10.003_bib0022
  article-title: Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2013.41
– volume: 139
  start-page: 323
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0048
  article-title: Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2010.03.052
– volume: 1864
  start-page: 804
  year: 2018
  ident: 10.1016/j.hbpd.2022.10.003_bib0144
  article-title: Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12
  publication-title: Biochim Biophys Acta Mol Basis Dis
  doi: 10.1016/j.bbadis.2017.12.001
– volume: 66
  start-page: 55
  year: 2017
  ident: 10.1016/j.hbpd.2022.10.003_bib0019
  article-title: Non-alcoholic fatty liver disease with and without metabolic syndrome: different long-term outcomes
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2016.06.009
– volume: 74
  start-page: 743
  year: 2003
  ident: 10.1016/j.hbpd.2022.10.003_bib0148
  article-title: Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2003.07.017
– volume: 75
  start-page: 1691
  year: 2015
  ident: 10.1016/j.hbpd.2022.10.003_bib0142
  article-title: Wnt/β-catenin small-molecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stem-like cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-2041
– volume: 51
  start-page: 511
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0047
  article-title: Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity
  publication-title: Hepatology
  doi: 10.1002/hep.23337
– volume: 40
  start-page: 1461
  year: 2008
  ident: 10.1016/j.hbpd.2022.10.003_bib0010
  article-title: Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
  publication-title: Nat Genet
  doi: 10.1038/ng.257
– volume: 13
  start-page: 511
  year: 2009
  ident: 10.1016/j.hbpd.2022.10.003_bib0012
  article-title: Epidemiology and natural history of non-alcoholic steatohepatitis
  publication-title: Clin Liver Dis
  doi: 10.1016/j.cld.2009.07.005
– volume: 296
  start-page: G1248
  year: 2009
  ident: 10.1016/j.hbpd.2022.10.003_bib0045
  article-title: Inflammasome-mediated regulation of hepatic stellate cells
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.90223.2008
– volume: 136
  start-page: 133
  year: 2018
  ident: 10.1016/j.hbpd.2022.10.003_bib0153
  article-title: Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing NF-κB signaling and Wnt/β-catenin signaling
  publication-title: J Pharmacol Sci
  doi: 10.1016/j.jphs.2018.01.003
– volume: 99
  start-page: 1497
  year: 2004
  ident: 10.1016/j.hbpd.2022.10.003_bib0036
  article-title: Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2004.30159.x
– volume: 177
  year: 2020
  ident: 10.1016/j.hbpd.2022.10.003_bib0128
  article-title: Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2020.113942
– volume: 131
  start-page: 411
  year: 2009
  ident: 10.1016/j.hbpd.2022.10.003_bib0075
  article-title: Knockdown of tight junction protein claudin-2 prevents bile canalicular formation in WIF-B9 cells
  publication-title: Histochem Cell Biol
  doi: 10.1007/s00418-008-0546-0
– volume: 134
  start-page: 1655
  year: 2008
  ident: 10.1016/j.hbpd.2022.10.003_bib0056
  article-title: Mechanisms of hepatic fibrogenesis
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.03.003
– volume: 176
  start-page: 744
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0087
  article-title: Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2010.090667
– volume: 2020
  year: 2020
  ident: 10.1016/j.hbpd.2022.10.003_bib0101
  article-title: Heme oxygenase-1 suppresses Wnt signaling pathway in nonalcoholic steatohepatitis-related liver fibrosis
  publication-title: Biomed Res Int
  doi: 10.1155/2020/4910601
– volume: 15
  start-page: 11
  year: 2018
  ident: 10.1016/j.hbpd.2022.10.003_bib0004
  article-title: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2017.109
– volume: 110
  start-page: 371
  year: 2019
  ident: 10.1016/j.hbpd.2022.10.003_bib0155
  article-title: Dendrobium candidum extract inhibits proliferation and induces apoptosis of liver cancer cells by inactivating Wnt/β-catenin signaling pathway
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.11.149
– volume: 53
  start-page: 372
  year: 2010
  ident: 10.1016/j.hbpd.2022.10.003_bib0033
  article-title: A position statement on NAFLD/NASH based on the EASL 2009 special conference
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2010.04.008
– volume: 12
  start-page: 768
  year: 2016
  ident: 10.1016/j.hbpd.2022.10.003_bib0133
  article-title: Inhibition of wnt/β-catenin signaling in hepatocellular carcinoma by an antipsychotic drug pimozide
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.14718
– volume: 11
  start-page: 183
  year: 2005
  ident: 10.1016/j.hbpd.2022.10.003_bib0041
  article-title: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB
  publication-title: Nat Med
  doi: 10.1038/nm1166
– volume: 75
  start-page: 4803
  year: 2015
  ident: 10.1016/j.hbpd.2022.10.003_bib0111
  article-title: Histone deacetylase HDAC8 promotes insulin resistance and β-catenin activation in NAFLD-associated hepatocellular carcinoma
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-3786
– volume: 277
  start-page: 210
  year: 2014
  ident: 10.1016/j.hbpd.2022.10.003_bib0149
  article-title: Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/β-catenin signaling
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2014.03.008
– volume: 109
  start-page: E3186
  year: 2012
  ident: 10.1016/j.hbpd.2022.10.003_bib0054
  article-title: Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1119964109
SSID ssj0028856
Score 2.4668748
SecondaryResourceType review_article
Snippet Nonalcoholic fatty liver disease (NAFLD) is a global health concern associated with significant morbidity and mortality. NAFLD is a spectrum of diseases...
Nonalcoholic fatty liver disease(NAFLD)is a global health concern associated with significant morbidity and mortality.NAFLD is a spectrum of diseases...
SourceID wanfang
proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 333
SubjectTerms Chronic liver diseases
Fatty liver
Fibrosis
Oxidative stress
Steatosis
Wnt/β-catenin
Title Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1499387222002399
https://dx.doi.org/10.1016/j.hbpd.2022.10.003
https://www.ncbi.nlm.nih.gov/pubmed/36448560
https://www.proquest.com/docview/2743507999
https://d.wanfangdata.com.cn/periodical/gjgdybzz-z202304003
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEB6SDZReSv-7bRNUyK04a-vP8jGEhG1DcmlCcxOSJW8dUu8SO4fsofQR-ox9kmrW8tJSmkJOBtlji5E88w2abwZgl3IrqeUiUZnxCTeSJsarNBGlTb0Stsok8p1PTuX0nH-8EBcbcDBwYTCtMtr-3qavrHUcmURtThZ1PfkUsH3BVB4cXM_Q3IStcKFqBFv7H46np-u4SynRk4yKAkvJ0sid6dO8vtgFFgyldG-V5MX-5Z_-xp8rmk9TmWb2m0c6egyPIpQk-_1sn8CGb57Cg5N4WP4Mzj433cT6zvz8_gPznpq6IZiuYZCBTkzjSN215OvcYQev-XVLwv0GgfmqaW5dksp03S25wswNEg9y2udwfnR4djBNYhOFpOScdYmnWZnJUgqfW8epKaqiSq11pqxM7oK7r1KWK5dnpQqxlEtzyl0ABcoxaVNlOHsBo_Bt_wqIk4bnzBaW25I7KazlnAsjhTM-qygdQzaoTpexwjg2urjSQyrZpUZ1a1Q3jgV1j-H9WmbR19e482k2rIgemKPB1ulg_u-UEmupP_bWf-XeDYuuw0-HJymm8fObVodQngUgHcD1GF72u2E9e4YRb8CRY9iN20NHs9Dq2eXM3drlUi-xaz3aT_b6npN7Aw_xHX0u4lsYddc3fjvgo87uwObet2wn_gW_ABm_Dz0
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VrQRcEG-Wp5F6Q2ETv-Icq4pqS7t7YSt6s-zYWVKV7KqbHronfgK_kV-CZ-OsQIgicXUyiTW2Z76Rv5kB2KPcSmq5SFRmfMKNpInxKk1EaVOvhK0yifnOk6kcn_KPZ-JsBw76XBikVUbb39n0jbWOI6OozdGyrkefArYvmMqDg-syNG_BLsem1gPY3T86Hk-3cZdSoksyKgosJUtj7kxH8_pil1gwlNL3G5IX-5t_-hN_btJ8mso081880uF9uBehJNnvZvsAdnzzEG5P4mX5I5h9btqR9a358e078p6auiFI1zCYgU5M40jdrsjXhcMOXovLFQnPGwTmm6a5dUkq07bX5AKZGyRe5Kwew-nhh9nBOIlNFJKSc9YmnmZlJkspfG4dp6aoiiq11pmyMrkL7r5KWa5cnpUqxFIuzSl3ARQox6RNleHsCQzCv_0zIE4anjNbWG5L7qSwlnMujBTO-KyidAhZrzpdxgrj2OjiQvdUsnON6taobhwL6h7Cu63MsquvcePbrF8R3WeOBlung_m_UUpspX7bW_-Ue9svug6HDm9STOMXVysdQnkWgHQA10N42u2G7ewZRrwBRw5hL24PHc3CSs_P5-7artd6jV3r0X6y5_85uTdwZzybnOiTo-nxC7iL3-t4iS9h0F5e-VcBK7X2dTwLPwF7hREj
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Wnt%2Fbeta-catenin+signaling+and+its+modulators+in+nonalcoholic+fatty+liver+diseases&rft.jtitle=Hepatobiliary+%26+pancreatic+diseases+international&rft.au=Shree+Harini%2C+Karthik&rft.au=Ezhilarasan%2C+Devaraj&rft.date=2023-08-01&rft.issn=1499-3872&rft.volume=22&rft.issue=4&rft.spage=333&rft_id=info:doi/10.1016%2Fj.hbpd.2022.10.003&rft.externalDBID=NO_FULL_TEXT
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fgjgdybzz-z%2Fgjgdybzz-z.jpg